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Abstract
Next-generation sequencing (NGS) technologies have been remarkably ad-
vantageous in opening new paths for scientific research. The large-scale
generation of data has resulted in the advancement of tools for data analy-
sis, but the requirement to implement increasing amount of tools in a sys-
tematic way is still a vast question. In the initial analysis of distant NGS
datasets, we observed the need for an efficient framework for downstream
analysis of NGS data. Therefore, the web application titled “RanchNGS”
was developed. This particular web-framework aims to understand the
downstream and integrative analysis for various sequencing data such as
RNA-Seq, Ribo-seq and additionally ChIP-seq. RanchNGS benefits from
an efficient analysis in a reduced time frame and without the need of any
advanced programming skills. Furthermore, the role of transposable ele-
ments (TEs) in cellular senescence was revealed by studying distinct NGS
technologies.
TEs are segments of DNA that have the potential to be in-motion by
jumping from one location in the genome to another. Due to this rea-
son, they are also called as “jumping genes.” Long Interspersed Nuclear
Element-1 (LINE-1 or L1) are the only autonomous TEs currently active
in human and non-human primate genomes. Our study primarily targeted
a broad extent of L1 elements. The result of excessive oncogenic stress in
immortalized cells undergoing senescence were investigated. The current
study focused on the transcriptional and post-transcriptional mechanisms
that confer the cross-talk between L1 and host-defense machinery. It was
observed that the transcriptional and post-transcriptional regulation of L1
elements are diminished as cells undergo senescence that takes precedence
to the response activation of L1 elements at RNA and protein level. More-
over, we hypothesized that excessive oncogenic stress in immortalized cells
could be related to L1 retrotransposition, triggering double- strand breaks
and enabling cells to enter permanent cell cycle arrest.
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Chapter 1
Introduction
1.1 Central dogma of biology
Deoxyribonucleic-acid (DNA) is a complex molecule that carries hereditary infor-
mation in all living organisms. The structure of DNA is a double helix, which is
composed of two strands that are arranged in opposite orientation. It is composed
of pairs of chemicals called nitrogenous bases attached together with sugar and phos-
phate molecules. Jointly nitrogenous base, sugar and phosphate molecules are known
as a nucleotide. Each nucleotide in DNA is made up of four nitrogenous bases i.e.
adenine (A), cytosine (C), thymine (T), guanine (G). These bases are categorized
into purine and pyrimidine bases. Adenine and guanine are grouped into purines and
cytosine and thymine are grouped into pyrimidines [1]. The bases are linked with
each other via hydrogen bonds, whereby A pairs with T and C pairs with G.
The DNA molecule combined with histone proteins are wrapped into a structure
called chromosome. Humans have 23 pairs of chromosomes, in total of 46 chromo-
somes. Out of these, 22 pairs are known as autosomes and the remaining pair called
as sex chromosomes. In it, one pair of chromosomes inherited from the paternal
and the other pair of chromosomes inherited from the maternal [2]. Telomeres are
an essential part of the chromosome and they are located at the ends of a linear
chromosome. Genes are made up of a sequence of DNA or RNA, which encodes for
a functional protein [3]. Genes are considered as transcription units that can cor-
relate with different polypeptide chains with different functions [4]. In distinction
from DNA, Ribonucleic acid (RNA) is usually single stranded. The RNA structure
consists of ribose, nitrogenous bases and phosphate group. Whereas RNA nucleotide
also contains adenine, cytosine and guanine, thymine is replaced by uracil (U). Mainly
there are three types of RNA, ribosomal RNA (rRNA), messenger RNA (mRNA) and
19
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transfer RNA (tRNA). According to the central dogma of molecular biology, the ge-
netic information in DNA is transcribed to messanger RNA (mRNA) by the process
of transcription. The segment of DNA transcribed into mRNA is known as a mature
transcript [5]. The processed mRNA is further translated into proteins by the process
of translation. The essential enzyme for maintaining gene expression that synthesizes
mRNA in all eukaryotes is known as RNA polymerase II (pol II). Pol II is regarded
as integral foundation of transcriptional machinery [6]. Pol II interacts with generic
transcription factors during preintiation complex (PIC) and with different factors in
course of elongation and termination [7]. The RNA pol II structure is well compati-
ble for promoter binding and its initiation helps in relating with other transcription
factors to create the pre-initiation complex [8].
In the process of translation the message coded on mRNA is converted into a
sequence known as protein. A sequence of three bases in mRNA is referred to as
a codon. The genetic information contained in the codon represents a particular
amino acid. The ribosome complex plays an important role in protein synthesis. The
ribosome structure is made up of protein and ribosomal RNA (rRNA) and consists of
two subunits: the larger unit of ribosome is called 60-S and the smaller unit is called
40-S. The two subunits of ribosome are connected together and bind with mRNA
to form a protein. Transfer RNA (tRNA) performs an essential function in carrying
specific amino acids to proteins. The translation process is divided into three phases:
initiation, elongation and termination. In initiation, the ribosome mobilizes the start
codon AUG which is in the P-site to form the initiation complex. In elongation, at
distinct time each codon is read from the mRNA and the corresponding amino acid
is added to the protein chain. In termination, when a stop codon (UAG, UAA or
UGA) enters the ribosome, events are generated that allow the polypeptide chain to
be liberated from the tRNA [9].
1.2 Cellular senescence and DNA damage response
A range of genes involved in controlling cell growth and cell division. The cells are di-
vided in regular fashion through mechanism of cell-cycle. The continuous progression
of cell-cycle ensures intact replication of DNA by repairing defective DNA. During
cell-cycle, checkpoint responses play an essential role in maintaining DNA integrity.
In case of checkpoint loss, damaged DNA can be accumulated and further leads to
mutations. DNA damage checkpoint responses consist of upstream protein kinases
such as ATM and ATR, downstream kinases such as CHK1 and CHK2 [10]. There
20
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are three checkpoints in the cell cycle, first is at end of the G1 phase, second one is
at the transition of G2 and M phase and third one is at the M phase which generates
formation of two daughter cells.
1.2.1 Cellular senescence
In 1961, Hayflick showed that normal cells have limited capacity to divide in vitro
which is described as cellular senescence. There are various factors like DNA damage,
oxidative stress and oncogenic stress which leads to senescence. With the onset of
oncogenic stimuli, cells are unable to divide and enter a state of irreversible cell cycle
arrest [11]. Cellular senescence is regulated by two tumor suppressive pathways, in
particular the p53/p21 and p16INK4a/pRB pathways [12]. p16INK4a has been con-
sidered vigorous senescent biomarker in mouse and human tissues [13]. Apart from
changes in gene expression, there are other vast changes which also take place during
Cellular senescence namely increase in mRNA levels, secretion of numerous cytokines,
chemokines, growth factors and proteases. These are referred to as senescence asso-
ciated secretory phenotype (SASP) [12]. A fraction of chemokines and cytokines
in SASP can induce cells of immune system. Natural killer cells, macrophages and
T cells are among those allowing elimination of senescent cells. Whereas another
characteristic of SASP include inciting inflammation [14]. Suppression of the can-
cer development and promotion of tissue repair are two important functions covered
by cellular senescence and SASP [15, 16]. Expression of human telomerase reverse
transcriptase (hTERT) is known to cause immortalization in human fibroblasts cells
[17].
The structures located at the ends of linear chromosomes are known as telomeres,
which gets shortened with each cell division. Continuous cell division without the
presence of telomeres makes dysfunctional telomere. During DNA replication, incom-
plete replication of chromosome ends stimulates telomere shortening [18]. Further,
dysfunctional telomere are able to evoke defect in DNA resulting as DNA damage
response (DDR) by restraining already pursued DNA repair. Telomere shortening is
considered as a cancer-driving process.
There are numerous possible causes and consequences of cellular senescence. In
regard to causes, cellular senescence is described as a process of stress response and
it is also known to be associated by various mechanisms like telomere shortening, po-
tent oncogenic stimuli causes breaks in the epigenome, while certain tumor suppressor
mechanism are also activated by oncogenic stimuli. In regard to consequences, typi-
cally irreversible growth arrest can restrain tumor suppression mechanism. Potential
21
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senescent cells phenotype may also stimulate tissue repair and perhaps can also be
involved in the development of cancer and ageing [12, 14, 19] as shown in (Figure
1.1).
Figure 1.1: Schematic illustration of causes and consequences of cellular senescence.
The ovals in orange color indicates causes of senescence and ovals in grey color indi-
cates consequences of senescence. Figure adopted from [14] and modified.
1.2.2 DNA damage response
In human body, each cell obtains thousands of DNA lesions per day. The loss in the
repair of these DNA lesions may result in the obstruction of transcription, replication,
mutagenesis and cellular cytotoxicity. The network of recognizing, signalling and
repairing DNA lesions are known as DNA damage response pathway [20]. Upon DNA
damage, senescent cells can respond in multiple ways likewise as tumor suppression
mechanism by disrupting the division and growth of cancer cells. Moreover, other
strategies include tissue repair and enabling cells to aging. In order to maintain
the DNA integrity, cell cycle checkpoints and DNA repair pathways are activated to
prevent harmful mutations.
1.2.2.1 Sources of DNA damage response
There are numerous forms of lesions which leads to DNA damage in human genome.
22
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1) DNA damage by cellular cytotoxicity: This type of damage belongs to the cate-
gory of endogenous cellular processes. It includes: a) oxidation of bases by production
of reactive oxygen species b) alkylation of bases such as formation of 7-methylguanine
c) hydrolysis of bases such as deamination, depurination and depyrimidination d)
mismatch of bases: it occurs due to errors caused by DNA replication. After certain
threshold variety of mistakes caused by replication are no longer identified as errors.
This type of mutation are referred to as base-pair substitution mutation. Base-pair
substitution comprise of replacement with one purine to another or one pyrimidine to
another known as transitions. In another case replacement of purine with pyrimidine
are referred to as transversions. Similarly when replication errors are not rectified,
they tend to evolve mutation. This type of mutation constitute of insertion, deletion,
duplication, inversion and translocation where DNA fragment endure changes [21].
2) DNA damage by external agents: This type of damage belongs to the category
of exogenous cellular processes. It comprise damage due to ultraviolet radiation
(UV), ionizing Radiation (IR), other radiation effects including x-rays, gamma-rays.
These type of radiation can damage DNA in form of single-strand breaks (SSBs) and
double-strand breaks (DSBs) [22].
Consecutively with involvement of p53 tumor suppressor, DDR arrests cell cycle
and cell cycle checkpoints are activated [14]. In turn, checkpoint activation halts the
cell cycle and allows time for DNA repair to take place. If unrepaired DDR pathway
triggers Cellular senescence or apoptosis. Stimulation of DDR pathway in senescent
cells has been considered as biomarker for further studies [18]. DDR has been related
to numerous health diseases. Moreover, infection of viruses along with retroviruses
can also stimulate DDR [20]. Cleavage of sugar phosphate in the DNA backbone
induces single strand breaks or DNA DSBs, which act as catalyst for DDR [23].
DSBs are regarded as rigid form of genotoxic stress. Telomere erosion is constrained
in accelerating DSBs [24]. Activation of oncogenes in normal cells lead to cellular
senescence which is also referred to as oncogene induced senescence (OIS) [23]. DSBs
are constrained in the progression of defective telomeres. DSBs are subjected to affect
the integrity of the genome. In which cell-cycle progression gets arrested when cells
react to DSBs in-turn generating DNA damage checkpoint response. DNA damage
checkpoint responses are reproduced by telomere-initiated senescence.
3) DNA damage by L1 retrotransposition: During the integration process of L1
elements, endonuclease (EN) activity encoded by ORF2 protein creates two nicks for
Double stranded DNA. If the nick is made above certain threshold or if nick is at site
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the damaged DNA. Then, it would lead to delay or failure of repair complex recruit-
ment. However, L1 retrotranspsosition (Section 1.4) has the potential in inducing
DNA damaging event [25, 26].
1.2.3 DNA repair mechanisms
In response to each type of DNA lesions, the cell has developed relevant repair pro-
cess to overcome generated lesions. DNA damage is either repaired by direct repair
system or excision repair. DNA polymerase such as polymerase-δ are involved in the
repair caused by replication errors. Base-excision repair (BER) are associated with re-
pair of damaged DNA caused by cellular metabolism such as reactive oxygen species,
methylation, deamination and hydroxylation. It comprise of DNA glycosylases and
AP endonuclease [27]. The repair mechanism for the damaged DNA caused by ex-
ogenous agents such UV light, IR are referred to as nucleotide excision repair (NER).
The defects caused by NER includes xeroderma pigmentosum, cockayne syndrome. It
occurs two NER pathways namely global genome NER (GG-NER) and transcription
coupled NER (TC-NER). Interestingly, NER takes place in the cells whose genes are
actively involved in the transcription on DNA. Consecutively, it inhibits elongation
of RNA polymerase [27]. The selected genes involved in repair of NER consist of
XPA, XPG, ERCC1-XPF, XPC-RAD23B [28]. During DNA replication, mismatches
of bases occurred in the process are repaired by mismatch repair (MMR). Defective
MMR has been identified in Hereditary nonpolyposis colon cancer (HNPCC). MMR
assist in eliminating nucleotide mispaired by DNA polymerases and insertion/deletion
loops can be found during replication or recombination [27].
DSBs are considered to be risky, if not repaired can induce genomic rearrange-
ments. Whereas, there occurs two types of mechanisms to repair DSBs 1) non-
homologous end joining (NHEJ): It involves the association of broken ends. It re-
quires the proteins which can recognize the damaged ends and bring them together
for ligating such as Ku is the well-known essential protein. 2) homologous recombina-
tion repair (HER): In it the broken ends are repaired by using one of sister chromatid
or homologous chromosome as template. Two of the crucial proteins associated with
homologous recombination are BRCA1 and BRCA2 [29].
1.2.4 The p53 signaling pathway
The p53 plays crucial role in the tumor suppressive DNA damage response.Therefore,
p53 also known as a tumor suppressor gene [30]. p53 acts as a transcriptional regula-
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tor by maintaining various types of stresses like to activate cell cycle arrest or induce
apoptosis in suppression of tumor development. p53 helps in sustaining genome in-
tegrity. In unstressed or normal cells, p53 is in very unstable form. During which
p53 forms complex with mouse double minute 2 (MDM2) or human double minute 2
(HDM2) to ensure degradation of p53 protein in presence of E3 ubiquitin mediated
ligase [31]. Upon different forms of stress such as oxidative stress, oncogene activa-
tion, DNA DSBs, hypoxia resulting in DNA damage, p53 is activated by increasing
its expression levels and DNA repair mechanism are triggered. In it p53 induces DNA
repair genes,if repaired then it goes back and cell cycle continuous. If not repaired,
p53 induces two different processes such as senescence and apoptosis (state of pro-
grammed cell death). Thus, p53 is also known to conserve stability of the human
genome. But when p53 is inactivated, then damaged DNA progresses continuously
without check, then cancerous cells are formed. p53 has been specified as one of the
mutated genes found in about half of all human cancers [32]. The mutations which
are found commonly in human tumor cells are missense mutations [33]. p53 has been
considered best known biomarker in Cancer cells [34]. p53 has been referred to as
”Gate-keepers of cells” by deciding either to eliminate damaged cells or arrest those
damaged cells. Due to its well-known regulation in timely functions, p53 has been
cited in more than 40,000 research papers [35]. p53, a tumor suppressor gene is in-
volved in the suppression of retrotransposon activity [36]. In p53 mutant cells, it has
been shown that DNA damage response can be caused by L1 retrotransposition [37]
in turn proceeding to apoptosis [38]. DNA double strand breaks (DSBs) are initiated
by L1-encoded endonuclease which might related to L1 retrotransposition [26].
1.3 Transposable elements
In 1940s, Barbara McClintock discovered Transposable elements (TEs) in maize
plants.TEs are distinct pieces of DNA which move from one location in the genome
to another. Therefore, they are also referred to as ”jumping genes”. The early theory
about TEs was rejected by scientific community. They were treated as ”Junk DNA”.
It took a long time before it got accepted. TEs have known to account for nearly half
of the human genome (Figure 1.2). TEs are now being acknowledged as substantial
part of human genome,exhibiting crucial role in processes along with gene expression
regulation, genomic instability and genome evolution [39, 40]. TEs are well-known
to regulate gene expression in mammalian genomes.Thus it’s also referred as “con-
trolling elements” [41–43]. TEs have the significant characteristic to regulate the
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expression of nearby genes, whereby controlling both at transcriptional as well as
post-transcriptional level [44]. TEs transcription and integration are known to be
activated due to stress [45]. TEs are well integrally distributed in heterochromatin,
particularly in centromeres and telomeres. Due to their entanglement in heterochro-
matinization, TEs constitute to play a role in gene regulation. TEs possess two
attributes which distinguish them from other genetic factors. One characteristic of
those attribute is changing the genetic environment, in which they are considered to
be mobile. The other attribute resembles the peculiar capacity to multiply themselves
during the retrotransposition process [46]. TEs are categorized into two groups: DNA
transposons and retrotransposons [42, 47].
1.3.1 DNA transposons
DNA transposons constitute about 3 % of the human genome (Figure 1.2). They
tend to act through a ”cut and paste mechanism”, and are categorized under Class II
transposable elements [49]. Whereas currently they are no longer active in the human
genome, but there is evidence that the last family was active back during primate
evolution of 37 Mya ago [40]. Majorly, DNA transposons are classified into three
evolutionary groups: anthropoid specific (40-63 Mya), primate specific (64-80 Mya)
and eutherian wide (80-150 Mya) [50].
1.3.2 Retrotransposons
Retrotransposons are also known as RNA transposons. Retrotransposons, mobilize
through copy and paste mechanism by use of RNA as an intermediate.They are cate-
gorized under Class I transposable elements [49, 51]. Replication of retrotransposons
occurs through reverse transcription of RNA and integration of emerging cDNA into
another location [52]. Retrotransposons are further categorized into two classes: Long
Terminal Repeats (LTR) and non-LTR elements.
1.3.2.1 Long Terminal Repeat(LTR) retrotransposons
Retrotransposons involving LTR elements are referred to as Human Endogenous
RetroViruses (HERVs). LTR retrotransposons contain Gag: group-specific antigen,
Pol: polymerase, Env: envelope protein (Figure 1.3). HERVs constitute about 8˜.3
percent of the human genome(Figure 1.2) [40, 55]. HERVs existed around 25 million
years ago in our ancestors, mostly in apes and Old World monkeys. The HERVs which
have been associated with other diseases comprise HERV-K, HERV-H, HERV-W [56].
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Figure 1.2: Distribution of genomic content of human genome (hg19). Figure drawn
based on [48].
HERVs are considered to be the cause of autoimmune rheumatic diseases. Among
them mainly are Rheumatoid Arthritis (RA) and Systematic Lupus Erythematosus
(SLE) [57]. During early embryogenesis, human specific Endogenous retroelements
(EREs) transcription has been repressed mainly by KRAB/KAP1 system through
histone methylation, histone deacetylation and DNA methylation [58]. EREs uses
sequence-specific mechanisms for the silencing of retrotransposable elements [59]. En-
dogenous retroviruses (ERVs) are also responsible for configuring p53 transcriptional
network in a species-specific manner. Approximately 1500 human ERVs LTR ele-
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Figure 1.3: Classification of transposable element and its structure. (A) Human
endogenous retroelements-K (HERV-K) belongs to class of LTR retrotransposons
consists of two long terminal repeats (LTR) along with Gag,Pol and Env. (B) L1
elements are specified to class of non-LTR retrotransposons. L1 structure comprised
of two open reading frames (ORFs) along 5’UTR and 3’UTR (C) Alu element also be-
longs to non-LTR retrotransposons. Alu structure consists of left and right monomer
connected with A-rich linker zone. Figure drawn based on [53, 54].
ments are adjoined by p53 DNA binding sites. The pattern of LTR10 and MER61
families in ERV [60] have been attributable to anthropoids which include New World
monkeys (squirrel monkey and marmoset) and Catarrhini (Old World monkeys i.e
rhesus monkey and apes i.e. humans). The families of LTR10 and MER61 are linked
to provirus HERVIP10 and HUERS-P3B respectively. Since primates, LTR elements
were established in LTR10 and MER61 families. The p53 site was existent in LTR
elements of LTR10 retroviruses family, but later it got extinct over a period of time.
Whereas the MER61 family showed absence of p53 site but later it obtained p53 site
through mutations [61]. HERV-K elements are the recent one to be shown active
in various genomes of catarrhines (Old World monkeys, apes and humans). HERV-
K113 is one of the prominent possibly provirus still active in humans. HERVs are
considered to be a residual of ancient germ-cell infections [62].
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1.3.2.2 Non-LTR retrotransposons
Non-LTR retrotransposons, as the name distinguish does not constitute of Long ter-
minal repeats. Non-LTR retrotransposons are characterized into autonomous and
non-autonomous retrotransposons [63]. Long Interspersed nuclear elements (LINE-1
or L1) are classified under autonomous retrotransposons (In detail Section 1.4). Alu
and SVA elements are classified under non-autonomous retrotransposons [54]. Alu
and SVA elements together constitute of about approximately 13 % of our genome
[64] (Figure 1.2) . Alu and SVA elements belongs to the Short interspersed Elements
(SINE) retrotransposon family [65] Active Alu elements in humans are around 300
base pairs (bp) in length [66]. Alu elements consist of enhanced regions which are
gene-rich whereas L1 elements consist of enhanced regions which are gene-poor. Alu
elements are also capable retrotransposition,which are attributed as master or source
elements. Alu retrotransposition are also distinctly altered by APOBEC proteins.
RNA polymerase III (Pol-III) plays an important role in retrotransposition of Alu
elements [67]. In evolutionary structure, Alu elements belong to the class of primate
specific which are 6˜5 million year old [68]. Alu structure comprises of two monomeric
sequences derived from signal recognition particle (SNP) which is part of 7SL RNA
gene [40]. Left monomer of Alu structure consist of internal RNA polymerase III pro-
moter, divergent from right monomer that consists of adenosine-rich sequence.During
diverse periods of evolutionary history,different families of Alu elements have been
evolved. Ancient Alu elements were identified as J subfamily, recent (Middle-aged)
Alu elements are categorized into S subfamily (Sx, Sq, Sp, Sc) and youngest Alu ele-
ments subfamily are classified under Y subfamily: Ya5 and Yb8 are most prevailed in
humans. Alu elements are known to have extensive influence during gene-expression,
splicing and RNA-editing. Insertion of Alu elements into human genome have been in-
dicated as a contribution in human genetic diseases [69, 70]. The SVA structure have
been comprised of Alu sequence, variable number of tandem repeats (VNTR), and a
sequence inferred from 3’ end of HERV-K10 element (SINE-R) [54]. In mobilization,
SVA elements have been pretended to benefit from L1 protein mechanism.
1.4 Long Interspersed Nuclear Elements 1 (LINE-
1 or L1)
L1 belongs to non-LTR retrotransposon family. In humans, L1 retro-transposons
are currently known active and jumping along neuronal differentiation, embryonic
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and cancer development. Germline and somatic tissues have exhibited presence of
active L1 elements involved in affecting genome integrity [71–73]. L1s constitute of
about approximately 20 % of the human genome [48, 54, 64] (Figure 1.2). A full-
length active L1 element are around 6 kb in length. The human full-length L1 element
structure constitute of 5’untranslated region (UTR), two open reading frames (ORFs)
and 3’UTR confining with polyadenylation signal and a poly A (AATAAA) tract
(Figure 1.3). 5’ UTR encompasses significant RNA polymerase II (polII) as internal
promoter, responsible for inducting L1 transcription. The ORF1 which consists of 40
kDa protein (ORF1p) encodes RNA binding protein [74, 75]. Whereas ORF2 consists
of 150 kDa (ORF2p) protein encodes endonuclease and reverse transcriptase activities
[40, 76–80]. In an average human genome contain of about 80-100 L1s, capable of
retrotransposition [81].
Since around 100 million year (Myr) ago, L1 elements have been evolving and
replicating in mammalian genomes.During human evolution,L1 elements has evolved
into different L1 subfamilies from L1PA16 to L1PA1 (L1Hs) [PA depicts primates]
with Homosapiens specific L1 element (L1Hs) being the youngest one [82–84]. Par-
ticularly in our ancestral genome, two-primate specific KZNF genes have emerged to
inhibit of diverse families of non-LTR retrotransposons. ZNF91 have sustained struc-
tural changes and linked to repress SVA elements. ZNF93 have evolved to repress
primate-specific L1 lineage until 12.5 Myr ago. While in L1PA3 subfamily, firstly
it created a deletion of 129-bp and since then liberated from ZNF93 restriction. Al-
though, the deletion is present in half of L1PA3 elements, in which a shorter version in
L1PA3-6030 subgroup while a longer version in L1PA3-6130 subgroup. Nevertheless,
intact binding site of ZNF93 is present in L1PA4-L1PA6 families [85].
1.4.1 L1 retrotransposition
L1 retrotransposons move inside the human genome through jumping. They are also
known as ”jumping genes”. L1 jumping can result into a mutation, if its inside a gene.
L1Hs insertions have emerged during human evolution and may be raised in current
human population [86]. L1 insertion which are known in causing diseases are essential
in understanding mechanism about change in gene expression by retrotransposons
[80]. A conventional L1 integration site in target DNA consist of 5’-TTTT/AA-3’
[76, 87, 88]. Insertions associated with L1 and Alu elements are involved in causing
alteration in gene expression and further yields to human diseases [71] [89]. The role
of L1 in tumor initiation has been discussed, through the identification of somatic
L1 insertion in colo-rectal cancer (CRC) by disturbing adenomatous polyposis coli
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(APC) exon [90]. The advent of sequencing, allowed us to look in detail for somatic
L1 insertion and second L1 insertion was reported after 20 years in APC exon for
CRC which showed insertions are responsible for initiating tumorigenesis [91]. In
p53-adequate cells, L1 activity can also help in initiating DNA damage leading cells
to apoptosis. In this case, p53 function to inhibit such L1 insertion by protecting
human genome. L1 insertion inside an exon can tend to decrease gene expression
[37]. In L1Hs family,p53 contrarily effects expression of L1 elements [36].
Figure 1.4: Mechanism of L1 retrotransposition.L1 element in nucleus is transcribed
and exported to cytoplasm for translation. Along with L1 RNA, ORF2 (colored in
orange) and two ORF1 (colored in yellow) molecule forms RNP complex. ORF2
protein linked with L1 RNA is further imported in nucleus from cytoplasm, in it
L1 RNA is reverse transcribed and integrated into the new genomic site by TPRT
process.Figure re-drawn based on [92] and modified.
The translation of ORF1 and ORF2 encoded proteins takes place in the cyto-
plasm, wherein it accumulates into ribonucleoprotein particle (RNP) encoded by L1
RNA transcripts [93–95] (Figure 1.4). RNP is considered one of the essential com-
ponent of L1 retrotransposition. RNP is exported from cytoplasm into nucleus for
L1 integration within human genome, occur by the process of target primed reverse
transcription (TPRT) [54, 71, 79, 96–98] (Figure 1.5). Whereas RNP and TPRT
carries out essential role in L1 replication [99, 100].In L1 retrotransposition process
it is considered that endonuclease cuts genomic DNA releasing 3’ hydroxyl, which
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plays important role as primer for further reverse transcription of L1 RNA by reverse
transcriptase [76, 101].
L1 retrotransposition (Figure 1.4) tend to occur during development of cells, here
described as somatic mosaicism [73, 102]. L1 retrotransposition is capable of causing
human diseases [76]. L1 retrotransposition tend to take place mainly in early embry-
onic development [103, 104]. L1 elements are also reported to be active in the brain,
mainly in the hippocampal region [105]. Previous studies have shown during the ini-
tial stage of neuronal differentiation, Sox2 expression can play vital role in controlling
L1 transcription and retrotransposition [106]. Although, L1 retrotransposition have
demonstrated to be higher in neural progenitor cells (NPCs), derivative from human
embryonic stem cells (hESCs) [107]. Since L1 retrotransposition are also involved in
causing particular genetic variation in humans [108]. During TPRT, ERCC1/XPF
performs an verification role at cDNA synthesis step [109]. Integration of L1 ele-
ments at DNA damage sites have shown in deriving repair of DNA by process of
non-homologous end-joining (NHEJ) in human cells [97] [110]. Endonuclease activity
of ORF2 in L1 element has shown its relevance with DSBs by trigerring various cel-
lular responses inclusive of apoptosis, cellular senescence, cell-cycle checkpoints and
DNA repair responses [111].
1.5 Transcriptional regulation in L1 retrotrans-
posons
[Kru¨ppel-associated box domain(KRAB)- associated protein-1] (KAP1) also known as
TRIpartate motif-containing protein 28 (TRIM28). TRIM28/KAP1 has been linked
in arrangement with different zinc finger proteins family (ZFPs) of Kruppel associated
protein family (KRAB) [112–116]. TRIM28/KAP1 have also displayed interactions
in gene repression [58, 87]. TRIM28/KAP1 which consist of RING-B box-coiled-coil
(RBCC) motif and it’s constituted of RING finger, two B box zinc fingers and coiled
coil domain. TRIM28 cooperates with KRAB to be inducted into DNA [87, 117]. The
two adjoining domain namely PHD (Plant homeo domain) and BR (Bromo domain)
are present at C-terminus and play major role in trans-repression of target genes.
BR domain interacts with Mi/NuRD complex through sumoylation and SETDB1
Histone methyltransferase that advances through trimethylation of Histone 3 on ly-
sine 9 (HeK9) on chromatin.TRIM28/KAP1 associates with area of heterochromatin
through heterochromatin particle (HP1) [114, 118]. TRIM28/KAP1 have shown es-
sential role in DNA repair mechanisms and transcriptional regulation [87]. KAP1 acts
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Figure 1.5: Diagrammatic representation of TPRT mechanism during L1 retrotrans-
position. In TPRT mechanism, L1 endonuclease cleaves first stand of target site
by use of L1 RNA as template and executes reverse transcription of first strand of
cDNA. The next cleavage and synthesis of second strand of cDNA occurs few bp
downstream in comparison to first cleavage, with the use of first strand of cDNA as
template. After completion of DNA synthesis and reparation, modified L1 element is
formed associated with TSDs. Figure re-drawn based on [79]
as transcriptional repressors in early embroyonic stem cells via through DNA methy-
lation [58]. DNA methylation has been involved in silencing of retro-transposable
elements in distinct somatic cell types [119]. Most of L1 elements are highly methy-
lated in normal somatic cells. Although hypomethylation prevails in cancerous cells,
by that it increases transcription of L1 elements. DNA methylation tend to be re-
quired in suppression of L1 promoter. Therefore, DNA methylation also plays an
essential role in regulation of L1 elements [120].
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Figure 1.6: Typical illustration of transcriptional regulation mechanism by KAP1.
Figure adopted from [87] and modified.
In an evolutionary arms-race of L1 element with KAP1/TRIM28, For every L1s
sub-family may have been identified by KAP1 to KRAB-ZFP complex but thereafter
KAP1 acquired mutation and binding got rejected. In recent L1 subfamilies, KAP1
has been recruited by sequence specific but may have acquired mutation restrain-
ing through base line expression. Youngest L1s (L1Hs) are remarkably transcribed
and not yet identified by KRAB-KAP1 system. Recent finding exhibit youngest
(L1Hs) lineage generates small RNAs known as Piwi-Interacting small RNAs (piR-
NAs) to regulate its expression through DNA methylation in human early embryonic
stem cells. Furthermore, if L1 escapes the repression control from KAP1/TRIM28
transcriptionally then L1 retrotransposition has been noticed to be blocked post-
transcriptionally by APOBECs proteins [58](Figure 1.7).
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Figure 1.7: Typical illustration of evolutionary arms race between L1 elements and
KRAB-ZFP. It shows the relation of L1 evolution with host evolution. Figure adopted
from [58] and modified.
1.6 Post-transcriptional regulation in L1 retro-
transposons
Epigenetics and post-transcriptional processes are the prerequisites for normal tissue
development and gene expression [121]. Previous studies have shown the vast insight
information can be gathered at RNA level.The pre-mature RNAs must undergo post-
transcriptional processing to form mature RNAs. RNA molecules are involved in vast
range of post-transcriptional modifications particularly 5’ capping, 3’polyadenylation,
RNA splicing and RNA editing[121–123].
1.6.1 Characterization of RNA editing
RNA editing has been considered one of the post-transcriptional modification pro-
cess, which involves changes in the nucleotides of RNA molecule and initiates protein
diversity. RNA editing has been studied a prerequisite for maintaining gene expres-
sion in mammals. RNA editing consists of two specific mechanisms like substitution
editing and insertion/deletion editing. Substitution editing involves modifications of
individual nucleotides. It constituted two types of substitution editing particularly
A-to-I editing which include conversion from A to I nucleotide performed by ADAR
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(adenosine deaminases acting on RNA) family [124, 125] of enzymes and the other one
involving C-to-U editing [126, 127] which include conversion from C to U nucleotide
executed by cytidine deaminase enzyme for APOBEC (apolipoprotein B mRNA edit-
ing enzyme) family of enzymes [128, 129]. ADAR enzyme family has been mostly
associated in brain tissue [130]. After the editing of C-to-U, sheared protein ApoB48
is transported to the cytoplasm [127].The other type Insertion/Deletion editing con-
stitute of insertion or deletion of RNA nucleotides. RNA editing has been related to
diseases like epilepsy, brain tumor, amyotrophic lateral sclerosis (ALS) and other can-
cerous associated diseases [128] [129]. Activation-induced-cytidine deaminases (AID)
are involved in regulation of somatic hypermutation (SHM) and class-switch recom-
bination (CSR) activities. AID has been related in activating DNA DSBs [131].
APOBECs family play a pivotal role in innnate immune response to infection by
retroviruses and also in regulation of other viruses like HIV-1, hepatitis B virus, hu-
man T cell lymphotropic virus and retrotransposons [132–136]. APOBECs illustrate
major part in regulation of L1 elements (Figure 1.7). In respect to non-LTR retro-
transposons such as L1 elements, at post-transcriptional phase APOBECs has been
involved in inhibition of L1 retrotransposition before integration process into genome
[109, 137–139]. APOBECs family of proteins has been involved in inhibition of viruses
and retrotransposons [140]. By virtue of APOBEC3B entanglement in deamination
of cytidines at single-stranded (ss) DNA. APOBECs is well-known to be expressed in
various types of cancer cell lines. APOBECs is considered as a huge cause of mutations
in different types of cancers. These mutations are accelerated by enzyme responsible
for cytosine-to-uracil deamination [141]. RNA-sequencing (Whole transcriptome se-
quencing) has proven to be distinguished mechanism in RNA-editing analysis [142,
143]. ADAR is an constituent of adenosine deaminases acting on RNA family. The
enzymes from these families are subject to deamination of adenosine(A) to inosine(I).
Lately, studies have shown adequate portion of ADAR gene are commonly to L1
elements [144].
1.6.2 Chimeric transcripts
Transcriptomics profiling have made possible detection of Chimeric transcripts.
Chimeric transcripts are described to form as result from fusion of two genes [145]
(Figure 1.8). Gene fusion has been characterized a mechanism in which whole or
parts of sequences from two or more different genes are conjugated to form chimeric
transcript resulting in rearrangements of DNA or RNA. TEs likely promote gene
fusions by reconciling gene duplications, straightly engaged in fusion and supporting
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the access of reverse-transcriptase required in transposition [146]. Gene-fusion arch-
ing to chimeric gene or transcript are root cause of translocations in distinct types
of leukaemias, malignent disorders and sarcomas [147, 148]. Chimeric transcripts are
considered as potential biomarkers in deeper understanding for cancer progression
and development [149]. In our study, we aimed to understand the formation between
full length L1 elements and genomic regions in senescent cells distinguished from
immortalized ones.
Figure 1.8: Conventional illustration of chimeric transcript formed with fusion of
exons from different genes. Gene A showcased in blue color while gene B showcased
in orange color.
1.7 Next-generation-sequencing
In 1977, Sanger and his colleagues developed the cutting-edge method for obtaining
nucleotide sequence of DNA. This method is based on the chain termination method
also known as Sanger sequencing.The first genome sequenced from this technique
was from the bacteriophage φX174 [150]. Sanger sequencing was established on the
principle of dideoxynucleotide triphosphates (ddNTPs), identical to deoxynucleotides
(dNTPs) [151].In 1977 Maxam and Gilbert delivered another method for sequencing
DNA and their method was based on a chemical procedure [152].Sanger sequencing
is also referred to as “first generation sequencing” technology.
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In 2001, the international human genome sequencing consortium (IHGSC) and cel-
era genomics announced the draft sequence of human genome. The IHGSC planned
to finish the process of human genome sequencing over a three-year period [64, 153].
In 2004, with the successful completion of the first human genome sequence under
the IHGSC, marked the beginning era of sequencing technology referred to as next-
generation sequencing (NGS) [154]. In the same year the national human genome
research institute (NHGRI) planned a program to reduce the cost of human genome
sequencing to It initiated the development of various sequencing platforms over the
last decade: 454, Illumina, SOLiD, Ion torrent and Pacific Biosciences (PacBio).
These platforms were also referred to as “second generation sequencing” technolo-
gies [155]. There are numerous methods involved in sequencing technologies such
as template preparation, sequencing and data analysis [156]. The first NGS tech-
nology available on the market was the 454 system. This approach is comprised of
the mechanism of emulsion PCR and pyrosequencing. In case of pyrosequencing ap-
proach, fragmented DNA is isolated, ligated with adapters and separated into single
strands. Whereas emulsion PCR is used for clonal amplification [157, 158]. In 2005,
454 technology based on the pyrosequencing method was developed by Life sciences
(now Roche) [155]. In 2006, Solexa launched the Genome Analyzer (GA) and later
in 2007, it was acquired by Illumina. It is based on the mechanism of sequencing
by synthesis [159]. Currently, Illumina prevails the NGS market by manufacturing a
group of sequencers namely MiSeq, NextSeq 500 and HiSeq series [160].
In 2007, another NGS technology, sequencing by oligonucleotide ligation and de-
tection (SOLiD), was developed by applied biosystems (now Life Technologies). It is
based on the mechanism of sequencing by ligation. Color space coding is the main
feature obtained by the sequencing from the SOLiD system [155]. For sequencing,
fragments are amplified by emulsion PCR along with small magnetic beads [161].He-
licos biosciences is the first group to release the sequencer HeliScope, based on the
mechanism of single molecule sequencing [162]. The main advantage of this technol-
ogy is that it is not influenced by any bias in library preparation or during amplifica-
tion. It is mainly applied to non-amplifiable samples [163]. The various sequencing
technologies adapt different approaches to attach DNA to fragments like 454 and
Applied Biosytems/SOLiD use coated beads to attach DNA whereas solexa/illumina
and helicos bioscicences use chips to attach DNA [164].In the late of 2010, ion torrent
liberated a compact sequencer known as ion personal genome machine (PGM) [165].
It is based on semiconductor sequencing technology. It is the first sequencing technol-
ogy which does not use fluorescence and camera scanning. PGM is best suitable for
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small labs and clinical applications [159]. A detailed comparison of these technologies
is mentioned in Table 1.1.
Table 1.1: Characterization and relation of different sequencing platforms. The data
is gathered from [156, 159].SE: Single-end reads, PE: Paired-end reads, bp: base pairs
Gb: Gigabit, kb: Kilobit, min: minutes.
In early 2010, pacific biosciences (PacBio) launched a sequencer based on the
approach of single-molecule-rReal-tTime sequencing (SMRT) [166]. It uses estimation
of enzymatic reaction in real time. Together with nanopore sequencing [167], they
both are referred to as “third generation sequencing” technology [159, 168]. The
major benefit of PacBio over other sequencers is mainly long reads and less sequencing
runtime [155]. In PacBio, a metal film containing thousands of tens-of-nanometer
holes known as zero-mode waveguides (ZMW) is used and in it sequencing reactions
are carried out on silicon dioxide chips [163]. Most NGS platforms have developed
fairly over recent period of time, many of them are constructed to produce short
sequence reads. Nanopore sequencing developed to overcome the drawback of other
techniques attaining long sequence reads over a short period of time [167]. The
protein MspA has shown greater importance in developement of nanopore sequencing
technology [169]. Nanopore sequencing also uses a technique based on single molecule
in real time. Although this technique does not require the prerequisite of library
preparation, it is possible to directly sequence the DNA or RNA. The accessible
sequencer on the market which adapts this technology, the MinIONTM, was launched
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by oxford nanopore sequencing technologies [155, 170]. Since the advent of sequencing
of the human genome and the study of further model organisms like mouse and
c.elegans enabled researchers to illuminate the genetic foundations of complex human
diseases. The main applications of sequencing technologies include whole genome
sequencing, exome sequencing, RNA-seq, ChIP-seq, Ribo-seq and several others. Due
to abundant decrease in the cost of sequencing have generated enormous amount of
data in the area of genomics, genetics and transcriptomics. Consequently, the field
of bioinformatics was revolutionized with the demand to develop diverse tools to
perform data analysis. Despite immense success in NGS, to solve biological questions
in clinical diagnostics is still a big challenge. The diverse applications of sequencing
technology will propel new insights based on data-driven research in many fields.
1.7.1 Chromatin immunoprecipitation sequencing (ChIP-
seq)
Chromatin immunoprecipitation (ChIP) followed by high throughput sequencing
(ChIP-seq) has been extensively used as an approach to identify DNA binding pro-
teins on a genome-wide scale. It involves identification of transcription factors or
histone modifications [171–176]. The ChIP-seq has been quite influential in assessing
siganture of chromatin promoters,insulators and enhancers regions [177, 178]. In
a ChIP-seq experiment (Figure 1.9), cells grown in tissue culture are cross-linked
using formaldehyde. The cross-linked cells are adapted in buffer to isolate nuclei.
Nuclei are transferred to lysis buffer and sheared chromatin [179] is obtained by
sonication or enzymatic digestion by using micrococcal nuclease (MNase) [180]. In
immunoprecipitation antibodies are used against a specific transcription factor or
a DNA-binding protein of interest to identify a particular DNA-protein complex.
Afterwards reverse crosslinking is applied to separate the protein of interest from
ChIP-DNA. The library is prepared from immunoprecipitated samples and further
sequenced with the help of high-throughput sequencing. The derived reads from
sequencing are used for mapping to a reference genome and in addition to identify
protein binding sites. In relation to a ChIP-seq sample, preparation of a control
sample is essential. An input sample is obtained by crosslinking and sonication but
without immunoprecipitation [181, 182] (Figure 1.9.
Before the commencement of sequencing, chromatin immunoprecipitation has
been used coupled with microarray (ChIP-chip). ChIP-seq has been introduced to
overcome the limitations of noise and to achieve a higher resolution than in ChIP-
chip. Both techniques are involved in the functioning of gene regulation [175]. Along
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Figure 1.9: Schematic representation of Chromatin-Immunoprecipitaion followed by
sequencing (ChIP-seq). Figure re-drawn based on [183]and modified.
with transcription factors, several histone modifications like histone trimethylated at
lysine 4 (H3K4me3) methylation and H3K9ac acetylation are known to be enhanced
near promoter regions [176]. As in regard to histone modifications, nucleosome struc-
ture shows an essential role in scattering of histone variants through the chromosome.
It is always effective to compare ChIP-seq profiles of transcription factors to histone
modification profiles [184].
1.7.2 Transcriptome profiling (RNA-seq)
The transcriptome is the entire set of transcripts in a cell. Transcriptomics is nec-
essary in understanding the functional elements of the genome along with mRNAs,
long non-coding RNAs and small RNAs [185, 186]. The massive amount of transcrip-
tome data from several organisms can be obtained from the recent development of
parallel cDNA sequencing (RNA-seq) [186–189]. RNA sequencing provides a robust
mechanism in whole transcriptome analysis. Apart from its role in gene-expression, it
comprises post-transcriptional regulation alike in alternative splicing, RNA editing,
RNA degradation and translation [190]. In RNA-seq library preparation, total or
long RNAs are converted into cDNA fragments by the process of reverse transcrip-
tion and subsequent fragmentation. Then the sequencing adapters (grey) are added
at one or both ends (Figure 1.10). After the amplification, fragments are sequenced.
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Sequencing can be done at one end known as single-end sequencing or at both ends
known as paired-end sequencing [185, 186]. The Primary application of the RNA-seq
method was to obtain a transcriptome map in the yeast genome. RNA-seq analysis
reported wide expression of the yeast genome, where 74.5 % referred to as RNA-seq
tags [191].
Figure 1.10: Overview of RNA-sequencing (RNA-seq) experiment. Figure re-drawn
based on [185]and modified.
During transcription, single stranded RNA is synthesized from one of the two DNA
strands. In RNA-seq generation, when RNA is copied back to cDNA, it is difficult
to keep which of the two DNA strands was used to retrieve mRNA. To obtain this
information the strand-specific RNA-seq protocol emerged. The standard RNA-seq
library preparation protocol differs from that of strand-specific RNA-seq. Several
methods developed for strand-specific RNA-seq are divided into two main types. The
first type uses appending different adapters in a particular direction of the 5’ end and
3’end of the transcript. The second type specifies a strand by chemical modification
[192].
1.7.3 Ribosomal profiling (Ribo-seq)
Gene expression is the process which allows the conversion of information from DNA
to a functional form known as protein. DNA microarrays have been used extensively
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to study the regulation of gene expression at genome-wide, whereas RNA sequencing
at mRNA level [193]. But none of the above techniques focuses on protein synthe-
sis. Translation is the end process of gene expression which occurs in the ribosome.
It was initially discovered in bacteriophage R17, exact translational sites by RNA-
ribosome complexes [194]. Previously, the complex formation of the mRNA molecule
and the ribosome revealed translational regulation which is also known as polysome
profiling. Polysome profiling posed difficulty in determining the exact position be-
tween ribosome and mRNA when getting translated into protein. The method en-
countered a limited resolution and accuracy [195]. To overcome these limitations,
ribosome profiling was introduced [196, 197]. The ribosome profiling approach along
with high-throughput sequencing provides the key to monitor translation. Apart from
monitoring translation it also identifies translated sequences [197]. Each footprint rep-
resents the specific regions of transcriptome attaining translation. Footprints mostly
comprise of coding DNA sequences (CDS) which are also defined as protein-coding
sequences. The sequence in footprint fragment obtained from ribosome gives exact
location and description of mRNA getting translated on the transcript. The extent
of gene translation is directly proportional to amount of distinct footprint fragments
in deep sequencing [198].
During the protein synthesis, ribosome profiling is considered to be a measure-
ment for gene expression. It identifies the exact positioning of ribosome and mRNA
during translation. Ribosomal profiling has been considered equivalent to mRNA
abundance profiling, due to its involvement in measurement of gene expression. Ex-
perimental steps of ribosomal profiling (Figure 1.11) include generating ribosome
footprints, which is done after RNAase digestion of in-vivo translating polysomes.
Ribosome footprints can be specifically related to each translating ribosome. The
density of it can also play an important role in replacing mRNA abundance measure-
ment to quantify gene expression. Furthermore, these footprints are obtained and
converted into a DNA library by ligation of linker succeeded by reverse transcription
and circularization PCR (Figure 1.11). After which the recovered cDNA libraries are
further determined through deep sequencing [195, 197, 198].
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Figure 1.11: Diagrammatic illustration of ribosomal profiling experiment (Ribo-seq).
Figure re-drawn based on [197] and modified.
1.8 Aims and motivation of the thesis
In comparison to Sanger sequencing, NGS technologies have proven to be faster and
cost-effective. NGS technologies provide applications in diverse areas such as tran-
scriptomics, epigenomics and genomics. An accurate downstream analysis is consid-
ered to be a critical task in NGS data analysis. In coalition to our extensive research
with divergent NGS technologies, I speculate to profound a lack of platform which
focuses on examining downstream and integrative analysis for NGS data. Hence, I
demonstrate a web-based application for the downstream and integrative study of
DNA, RNA and protein level. The distinct NGS applications applied in Ranch-
NGS (Chapter 3 [Section 3.1]) web-interface includes exploration of transcriptomics
data (RNA-seq), identification of protein-DNA binding sites (ChIP-seq) and studying
translated RNA fragments (Ribo-seq). Furthermore, RanchNGS follows the principle
of the central dogma of molecular biology at one platform. NGS discoveries have great
influence in clinical applications by providing solutions for different diseases. The ob-
jective of this thesis focuses on to achieve and implement computational methods in
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evaluating NGS datasets which can be contemplated in answering particular biologi-
cal questions. I also applied RanchNGS during an elementary period of investigation
in detecting function of L1 elements throughout cellular senescence by enactment
with NGS datasets.
L1 elements are the only autonomous elements in the category of non-LTR retro-
transposons. While other retrotransposons essentially Alu elements uses L1 machin-
ery to be mobilized. In normal proliferative cells content of p53 is relatively high
in order to restrain L1 activity [36]. p53, a tumor suppressor gene is referred as
the guarding our genome due to its ability to restrain the L1 mobility, although the
mechanism is vaguely understood. In our research for immortalized human primary
BJ fibroblast cells (Chapter 3 [Section 3.2]), I aim to deeply understand if cells are
subjected to severe oncogenic stress then what kind of changes occurs for L1 elements
at transcriptional and post-transcriptional level. L1 expression can have distinct con-
sequences on the host system like insertional mutagenesis further advancing to DNA
double-strand breaks (DSBs). Insertional mutagenesis caused by active L1 or its open
reading frame (ORFs) may cause adverse effects on the host system. Despite if L1
element does not land into the coding sequence of a gene during integration into the
genome, it can still disturb its expression by altering the conformation of regulatory
sequences around it, as manifested by the activation of proto-oncogenes. This genre
of consequences due to L1 expression can percuss cells to enter cellular senescence or
apoptosis via DNA damage [199, 200](Figure 1.12).
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Figure 1.12: A typical diagrammatic representation of working hypothesis model.
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Next-generation sequencing (NGS) technologies have transformed measures in life
science research to look into an extent of human diseases. Due to the rapid decline
in the cost and time of sequencing. It has generated an immense amount of data
and to make use of data it demands to overcome challenges in data analysis. The
diverse NGS applications particularly transcriptomics study (RNA-seq), protein-DNA
interactions (ChIP-seq), ribosomal profiling of mRNA fragment (Ribo-seq) and its
analysis are described in this Chapter.
2.1 Alignment of sequencing reads to a reference
genome
The vast development in next generation sequencing enabled the production of enor-
mous amount of data to conduct studies that give detailed insights into a particular
organism. During the analysis of next generation sequencing data, mapping of reads
unto a reference genome is considered to be the most important and crucial step. The
main goal of alignment is to find locations of newly sequenced reads with respect to a
reference genome. Short reads obtained from a sequencing run are usually either from
one end of a DNA fragment (single-end reads) or from both ends (paired-end reads).
Mapping quality scores that are obtained from various algorithms for mapping of
reads to a reference genome, assist in the evaluation of mapping. The mapping tools
are classified into two types of algorithms either based on hash tables or Burrows-
Wheeler-Transformation [201]. At present, alignment software is divided into two
categories such as non-splice-aware aligner which include Bowtie [202], SOAP [203],
BWA [204], MAQ [203], mrFAST [205] and SHRiMP [206]. Whereas splice-aware
aligner include TopHat [207], TopHat2 [208] and STAR [209].Different alignment tools
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assist in providing the same format for further downstream analysis. The sequence
alignment map (SAM) format is supported by numerous tools. Binary Alignment
Map (BAM) format serves as a binary form of SAM. BAM format consumes less
space and easy to store in compressed file [204]
The hash table based algorithm uses the approach of seed and extend. It is based
on the identification of common k-mer substrings from reads and reference genome
as the first crucial step which is also known as seed detection. To further determine
distinct locations of reads in a reference genome, another accurate algorithm is applied
such as smith-Waterman [210] or needleman-Wunsch [211]. The aligner which apply
the hash based algorithm are MAQ [203], mrFAST [205] and SOAP [203]. However,
the hash-based algorithm identifies reads with errors by dividing reads into pieces
[212]. The major drawback of software applying the hash-based algorithm is its
dependence upon available large scale memory to index the human genome. To
overcome this fast short read aligners Bowtie [202] and BWA [204] based on Burrows-
Wheeler Transformation (BWT) [213] and FM-index have been developed. BWT
applies a property usually used for compression, that uses reversible permutations of
the characters in a string. It has a key strategy known as last-first (LF) mapping, in
which the ith occurrence of character ‘a’ in L and the ith occurrence of character ‘a’
in F correlates to the same occurrence in T. The method used in the FM-index is the
exact-match algorithm. The FM-index consists of an index linking the BWT with an
ancillary data structure.
Splice-aware aligners like topHat [207] initially map reads to a reference genome
with help of bowtie [202] and afterwards map reads to possible splice junctions. To
achieve splice junctions, it first computes all sequences within the donor and acceptor
sites and then uses the seed and extend approach [207] TopHat2 has been intro-
duced to implicate development over previous version. Along with improvements
in splice-alignment, TopHat2 also includes feature of read alignment across fusion
breaks. TopHat2 is widely accepted and enhanced to perform well against data ob-
tained from newer sequencing technologies producing longer reads [208]. TopHat2
[208] progresses read-alignment in three different ways 1) Transcriptome alignment
2) genome alignment 3) sliced alignment (Figure 2.1). Firstly, it performs Transcrip-
tome alignment in which it benefits from available annotation file. Transcriptome
alignment is considered highly agile in comparison to genome alignment. In case of
transcriptome mapping, reads which are not present in annotation are mediated as
unmapped reads. Tophat2 executes alignment of unmapped reads against genome. In
it reads in extension of exons are aligned, while not in range of introns. Tophat2 uses
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unmapped reads from genome alignment to further determine novel splice alignment
[208] TopHat2 made known in generating sensitive and accurate alignment. STAR
has been identified as highly efficient and faster in comparison to previous algorithms.
STAR can also identify Chimeric (Fusion) transcripts [209].
Transcriptome alignment
Genome	  alignment
Unmapped	   	  
reads
Reads	  in	  range	  of	  exon	  are	  mapped
Multi-­‐exon	   linking	  
reads	  are	  unmapped
Splice	  alignment
Novel	  exons
Reads
Annotated	  exons
Introns
Alignment	  of	  segments	  to	  genome
Alignment	  of	  segments	  to	  junctions
Re-­‐alignment
Figure 2.1: An Overview of Tophat2 workflow.Figure drawn based on[208] and mod-
ified.
2.2 ChIP-sequencing data analysis
Chromatin immunoprecipitation (ChIP-seq) in association with high-throughput par-
allel sequencing is a powerful technique for the identification of transcription factor
binding sites and histone modification patterns. ChIP-seq is commonly known as an
approach for recognizing genome-wide protein-DNA interactions. ChIP sequencing
plays an essential role in epigenetics research. Short read sequences obtained from
ChIP-seq are mapped onto a genome of interest as a prerequisite for detailed data
analysis. The primary steps involved in the analysis are quality checking, mapping,
peak calling, peak annotation and motif analysis.
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2.2.1 Peak calling
After mapping of reads, estimation of regions in genome enhanced with mapped reads
are referred to as proximate binding regions (peaks) [214]. Short read sequences from
ChIP-seq data are also known as tags. Tags that are mapped to genomic locations
are referred to as tag counts. In ChIP-seq, tag counts are retrieved from both strands
of the genome, forward as well as reverse strand. The main application of the peak-
calling approach is to retrieve the relation of the tag counts from both strands and
identifying the true protein-DNA binding sites [215]. The genomic region where
protein is bound has been represented as peaks. Model-based analysis of ChIP-seq
data (MACS) [216] is a highly preferable algorithm in comparison to other peak-
finding algorithms.MACS takes into account a control sample for the estimation of
tag distribution. MACS determines tag distribution based on the Poisson distribution
model. MACS splits forward and reverse tags from high quality peaks and aligns them
to Watson and crick tag centers.The distance between these forward and reverse tags
is measured as ’d’. In MACS, tags are shifted by d/2 in direction of 3’ends (Figure
2.2).
Figure 2.2: Peak modelling outline for ChIP-seq. (A) The bimodal distributions
enclosing transcription factor binding site established from + and – sequence reads
strand (Orange and green curves respectively) whereas distance (d) is studied as DNA
fragment length formed by antibody pull down. (B) The enrichment signal of ChIP
can also be attained from count of + and – sequence reads.Figure drawn based on
[173].
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Rather than using λBG for the whole genome, MACS applies λlocal for enriched
region as:
λlocal = max(λBG,[λ1K ],λ5K ,λ10K )
Where λ1K ,λ5K ,λ10K are for λBG predicted from 1kb, 5kb, 10kb windows centered
at the peak location of the control sample.
The p-value in MACS [216] for each candidate peak is calculated by λ1K . MACS
calls candidate peaks for p-value lesser than user defined value (default:10−5 ). The
correlation between ChIP-seq tag count and local are known as fold enrichment [216,
217]. In a ChIP-seq analysis, the control sample plays an essential role in detect-
ing enriched regions. It is usually referred to as input DNA and is prepared before
Immunoprecipitation (IP). Thus, Input DNA is used as a positive control, whereas
non-specific IP as IgG acts as a negative control. MACS evaluates the false discovery
rate (FDR) for each candidate peak. It detects three kind of peaks such as sharp,
broad and mixed. Sharp peaks are generally related to transcription factors at regu-
latory elements, while broad peaks are related to histone modifications [175] (Figure
2.3). In comparison to published peak-calling algorithm, MACS outperforms in peak
results [216, 218, 219].
2.2.2 Peak annotation
The main aim of peak annotation is to find an association of enriched ChIP-seq peaks
to various genomic parts like gene promoters, 5’UTR, 3’UTR, transcription start
sites (TSS), intergenic regions, introns and coding exons [221]. The output peak file
in BED format can also be uploaded for downstream analysis into the ‘RanchNGS’
Web-interface that have been developed in house as mentioned in (Section 3.2).
2.2.3 Gene ontology analysis
Furthermore, the peaks annotated with genes can be useful to attain different cate-
gories of gene Ontology(GO), associated with those particular genes. The GO terms
are classified into biological process, Cellular components and molecular function
[222]. This type of analysis can also be executed with help of ’RanchNGS’(Section
3.2).
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Figure 2.3: Representation of distinct types of ChIP-seq density profiles. Sharp peak
profile shown in green for CTCF,H3K4me3. Mixed peak profile shown in red for
RNA Pol II. Average sized broad peak profile shown in light-blue for H3K36me3,
H3K9me3,H3K27me3. Figure adopted from [220] and modified.
2.2.4 Motif analysis
De novo Motif analysis helps in identifying DNA binding motifs for particular peak
regions in a genome determined from a peak-calling algorithm [223]. It can also
help in analyzing a motif that is found around a complex for a protein of interest.
Besides comparison to previously known motif of protein from ChIP-seq experiment,
it supports in validation of experiment through motif analysis [221]. MEME [224] is
commonly utilized for recognition of DNA binding motifs.
2.3 RNA-sequencing data analysis
RNA sequencing (RNA-seq) enables high throughput sequencing of complementary
DNA (cDNA) for in-depth study of transcriptomics. RNA-seq yields quantification of
gene expression and identification of differentially expressed genes. Besides, RNA-seq
is also involved in several post-transcriptional modification mechanisms like detec-
tion of splice-site junctions [225] and identification of RNA editing sites [226]. The
algorithm designed for RNA-seq analysis for splice-site detection can also be used in
determining gene-fusion events. In our research study we have applied all applications
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of RNA-seq analysis such as gene-expression quantification, detection of differentially
expressed genes and identification of RNA editing sites.
2.3.1 Gene expression quantification
Mapping of raw sequencing reads are performed either to reference genome or to
transcriptome with a splice-aware aligner and non-splice-aware aligner respectively
(Figure 2.4). The essentiality of normalization on mapped reads is to eradicate fac-
tors which are not determined by biological interests. The various normalization
methods comprise of Total count (TC), Upper quartile (UQ), Reads per kilobase per
million mapped reads (RPKM) or Fragments per kilobase per million mapped reads
(FPKM). RPKM is related to single-end reads and FPKM is related to paired-end
reads. RPKM and FPKM are considered as an essential element in estimation of
transcript abundance [227]
RPKMi = 109 * Ci/l’i N
In the shown formula N is the total number of mappable reads, Ci is the number
of reads mapped to transcript i and l’i is the length of reads. Another important
normalization method for estimation of gene expression is Transcripts per million
(TPM) [228]. The main difference in normalization with TPM is to first normalize
with gene length and then with sequencing depth. The sum of all TPMs in each
sample are the same in case of TPM, whereas in RPKM and FPKM the sum for each
sample is different. TPM is calculated as
TPMi = 106 * Z * Ci/l’i N
Cuﬄinks [229] is a program that is available from the Tuxedo package. It takes
mapped reads as input to provide information about expression quantification for
RNA-seq data. It predicts transcript and gene abundances as RPKM and FPKM
values for single-end and paired-end reads respectively [230].
2.3.2 Differential expression
In RNA-seq studies, another necessary aspect is to identify differentially expressed
genes. It is attained by calculating statistical significance of differences in expression
for each gene between different conditions. For instance, if we have two samples from
the same patient with different conditions, one sample is from an affected part con-
sidered as treatment and another sample is from a healthy part considered as control.
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We assume that both samples have different amount of RNA transcripts. The ques-
tion that is often further investigated is which sample is having significantly higher or
lower number of transcripts in between samples for different conditions. To address
this matter, cuffdiff2 [229] was developed to evaluate expression at transcript level.
Cuffdiff2 [231] calculates expression of transcripts for each condition by computing
the number of their fragments. It also computes differential expression of transcripts.
Cuffdiff2 is based on beta normal binomial distribution model.
Another popular method applied to the identification of differentially expressed
genes is DESeq2 [232] which performs differential analysis based on two different
inputs either in form of a count matrix or calculated by htseq-count at gene level
(Figure 2.4). For count data, DESeq2 uses a generalized linear model (GLM) [233] to
distinguish between treatment and control. DESeq2 uses negative binomial distribu-
tion [234] (it is also known as gamma-poisson distribution) to evaluate differentially
expressed genes. DESeq2 applies gene ranking beyond a certain threshold of Log-fold
change and p-value to identify differentially expressed genes. The p-values utilized in
DESeq2 are adjusted by Benjamini-Hochberg procedure [235]. The difference between
a p-value and an FDR adjusted p-value is as follows: a p-value of 0.05 signifies that
5%of tests will report into false positives and a FDR adjusted p-value of 0.05 signifies
that 5% of significant tests will report into false positives. Additional open-source al-
gorithm named GFOLD (generalized fold change) [236] for determining differentially
expressed genes from RNA-seq data. The GFOLD values provides reliable log2Fold
Change.
2.3.3 Post-transcriptional RNA processing
The primary transcript generally undergoes further processing after it is formed by
RNA polymerase, which is described as post-transcriptional modification. Alterna-
tive splicing and RNA editing are among the important processes which take place
during post-transcriptional RNA modification [190]. The primary transcript consists
of three forms, namely tRNA, mRNA and rRNA that is processed into mature RNAs.
Alternative splicing is the process in which exons within a pre-mRNA transcript are
joined in several ways to code for multiple proteins. RNA-seq data is suitable in iden-
tifying splice junctions. Alternative splicing plays an essential role in the regulation
of gene expression [237]. An alliance between splicing and RNA editing is shown by
the formation of splice sites in pre-mRNA of adenosine deaminase that acts on dou-
ble stranded RNA (ADAR). The Mixture of Isoforms (MISO) [225] model benefits
from RNA-seq data for the computation of expression of alternatively spliced exons,
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Figure 2.4: Schematic representation of RNA-seq analysis workflow.
respectively on exon or isoform level [225]. Apart from splicing, RNA editing is also
a post-transcriptional process in which the information contained in the sequence of
RNA is changed. Mostly two types of RNA editing enzymes are involved in the mod-
ification of RNA molecule, namely ADAR (adenosine deaminase acting on RNA) and
APOBEC (apolipoprotein B mRNA editing enzyme) linked in Adenosine to inosine
(A-to-I) and Cytidine to Uracil (C-to-U) respectively [238].
2.4 Ribosome-profiling data analysis
After the transcription of genomic information into RNA, it is translated into protein.
Ribosomes play an important role in the translation of RNA into protein. Thus, they
are also known as the protein warehouse of cells. Formerly, gene expression studies
have been more focused at mRNA level. Hence none of the approaches focus at
protein level. Ribosomal profiling combined with deep sequencing (Ribo-seq) is used
to study in-vivo translation. It provides detailed information about protein synthesis.
Ribosome profiling data provides information about protein synthesis related to the
position of ribosomes on an mRNA. Whereas mRNA-seq and ribosome profiling share
high resemblance with respect to data analysis.
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2.4.1 Pre-processing and read mapping
The workflow for Ribo-seq data analysis includes several pre-processing steps, at first
the removal of adapter sequences from the raw sequencing reads by applying cutadapt
[239]. Then it involves the removal of ribosomal RNA (rRNA) sequences through fast
alignment with Bowtie2 [202]. Ribosomal profiling data contains substantial amount
of rRNA sequences. Elimination of rRNA sequences is considered to be necessary
step to get efficient results from downstream analysis. Furthermore, unmapped reads
obtained from above alignment are converted into a Fastq file with help of bedtools
[240]. The attained fastq file is used to perform an alignment to the trancriptome
either with Tophat2 [208] or by STAR [209].
2.4.2 Gene expression analysis
Gene expression analysis from ribosome profiling data gives insights about transla-
tional regulation at the protein level. As well as mRNA-seq data provides abundance
estimation at the level of transcriptional control, ribosome profiling allows it at the
level of translational control [241]. Thus, integration of mRNA-seq and ribosome pro-
filing data will reveal gene regulation both at transcriptional and translational level
Like in mRNA-seq. DESeq2 [232] is also applied for the estimation of differential ex-
pression of genes at protein level. The log2 fold-change is very effective in identifying
differentially expressed genes between different conditions. Poisson distribution is the
main model adopted by several algorithms for the calculation of log fold-change [242].
GFOLD [236] is a highly efficient method for recognizing up-regulation and down-
regulation of genes by means of log2fold-change. Further gene enrichment analysis
can be retrieved with the help of already available programs like DAVID [243] Gorilla
[244] or PANTHER [245].
2.4.3 Open reading frames detection
Ribosome footprints are retrieved after the sequencing of ribosome fragments. Ribo-
some footprints provide information about translated open reading frames (ORFs).
They define the explicit locations of start and stop codons whereas in mRNA-seq
these locations are not explicitly shown. While the 5’ UTR represents transcription
start site (TSS), the 3’UTR represents transcription end site (TES). In ribosome pro-
filing the area between start and stop codons consists of ORFs bound by ribosome
footprints. The coverage of this area is higher in comparison to the space between
start and stop codons [246](Figure 2.5).
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Figure 2.5: Schematic representation in comparison of Ribo-seq and mRNA-
seq.Ribosome footprints shows definite arrangement between start and stop codon
of a gene. Whereas mRNA-seq shows indefinite arrangement between 5’ and 3’ tran-
script boundaries. Figure drawn based on [246].
2.5 RNA-seq data preparation for senescent cells
RNA-seq data were obtained from [247] in Sequence read Archive (SRA) format.RNA-
seq samples were prepared from Immortalized human primary BJ fibroblast cells (by
human telomerase reverse transcriptase expression) which were cultured in Dulbecco’s
modified Eagle’s medium. In it retroviruses were transfected obtained from Ecopack
2 cells. The samples have been processed from Normal proliferation by activation of
tamoxifen-inducible RASG12V gene cultured in presence of 10-7 M 4OHT tamoxifen at
early 5 days indicated as pre-senescent state and at full 14 days indicated as senescent
state. Further all samples were sequenced by applying Illumina HiSeq-2000 platform.
The libraries obtained from above samples were 150 bp for paired end reads and 50
bp for single end reads with different replicates (Table 2.1).
We used online available datasets for analysis of different methods such as RNA-
seq, Ribo-seq data. The RNA-seq and Ribo-seq datasets for repetitive and RNA
editing analysis were collected from GEO [GSE42509] under the mentioned publica-
tion [247].
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Table 2.1: Sample representation of RNA-seq reads obtained from immortalized hu-
man primary BJ fibroblast cells. C1,C2,C3:Proliferation preS1,preS2:pre-senescence
S:senescence.
2.6 Analysis of RNA-seq datasets
We obtained RNA-seq samples of Immortalized human primary BJ fibroblast cells
from [247]. The RNA-seq reads (single-end and paired-end) were mapped to the
human (hg19) reference genome using STAR (v2.4.2a) [209]. We employed STAR
due to its feature in discovering novel splice junctions and as non-canonical splice
aligner in detecting chimeric transcripts and circular RNA. Mapped reads were sub-
jected to obtain raw counts for estimation of gene expression by using featureCounts
[248] from subread package (v1.4.6). To achieve this, we used gene transfer format
(GTF) for human-specific genome (hg19). Further, counted reads were administered
to normalization by adopting Transcript per million (TPM) method. We also ap-
plied GFOLD (v1.1.3) [236] for identifying differentially expressed genes. GFOLD is
extremely useful in datasets without replicates.
2.7 Repetitive elements analysis
We performed mapping of RNA-seq reads with the human reference genome (hg19)
by applying bowtie (v1.0.1) [202] short read aligner with a usage of –N 1 and –local
parameter for effective alignment. FPKM values were computed by cuﬄinks (v2.0.2)
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with default parameters [249] with use of GTF file format for specific repetitive ele-
ments (L1 & Alu) that were attained from UCSC genome browser [250]. This study
mainly focuses on non-LTR retrotransposons such as the L1 and the Alu elements
mentioned in (Section 3.1.3).
2.8 Data analysis workflow for detection of RNA
editing sites
We designed data analysis which involves several strict filters and focuses on identifica-
tion of true RNA editing sites with respect to L1 elements. We incorporated mapped
RNA-seq reads to execute local realignment, base-score recalibaration and candidate-
variant calling by using IndelRealigner, TableRecalibration and UnifiedGenotyper
tool with parameter stand call conf to 0 and stand emit conf to 0 and output mode
to EMIT ALL CONFIDENT SITES from Genome Analysis toolkit (GATK)(v3.5-0)
[251, 252]. In addition, we adapted few filtering steps of SNPiR [253] pipeline and
obtained variants were subjected to it. The intent variants were incorporated to var-
ious filtering steps to obtain true variants by removal of false-positive variant calls.
First, we filtered variants with quality up to 20. Then, the mismatches at 5’ reads
ends were removed in this step. Furthermore, the obtained variants were directed to
filter in L1 elements (Figure 2.6) We used shell scripting and bedtools [240] to retrieve
editing sites for each sample across full-length L1 elements. Motif pattern analysis for
editing sites was obtained by using MEME [254] from MEME suite (v4.12.0) [224].
2.9 Identification of chimeric transcripts fused
with L1 elements
We employed RNA-seq data reads to retrieve chimeric junctions. Mapping of RNA-
seq reads was performed by using STAR (v2.4.0.1) [209], which also generates chimeric
alignment to identify fusion transcripts. Chimeric junction file produced from STAR
was used for identification of chimeric transcripts with the usage of chimSegmentMin
15 for minimum chimeric segment length and chimJunctionOverhangMin 15 for min-
imum overhang of a chimeric junction. Primarily, it was splited into two separate
BED file for acceptor as well as donor sites. Further, splice site (donor and acceptor)
for particular sample was intersected across full-length L1 elements by using shell
scripting and bedtools [240]. Visualization of chimeric interactions for different con-
ditions such as for proliferation and senescence were accomplished by using RCircos
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Figure 2.6: Flow-chart characterizing RNA-editing analysis.
(v1.2.0) package [255]. Motif representation for insertional event was determined by
using Tomtom [256] from MEME suite (v4.12.0) [224].
2.10 Ribo-seq data preparation for senescent cells
Ribosome profiling (Ribo-seq) data were attained from [247] in Sequence read Archive
(SRA) format. Ribo-seq samples were prepared from Immortalized human primary
BJ fibroblast cells (by human telomerase reverse transcriptase expression) which were
cultured in Dulbecco’s modified Eagle’s medium. In it retroviruses obtained from
Ecopack 2 cells were transfected. Cells were mediated with different steps acquired
from Ribo-seq protocol. The samples were processed for various conditions in which
they were induced with tamoxifen-inducible by activation of RASG12V gene. Firstly,
it was considered at early 5 days indicated as pre-senescent state and at full 14 days
indicated as senescent state. Further all samples were sequenced by applying Illumina
HiSeq-2000 platform. The libraries obtained from above samples were 35 bp for single
end reads with various replicates [247].
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2.11 Estimation of L1 encoded proteins
We downloaded the Repeat masker track particularly for L1 elements obtained from
UCSC genome browser [250]. Then we extracted only Full length L1 elements from
the Repeat masker track of L1 elements and prepared BED file for it. We obtained
Ribosomal profiling (Ribo-seq) samples for Immortalized human primary BJ fibrob-
last cells from [247]. Firstly, adapter sequences were removed from raw fastq reads.
Then obtained reads were subjected to remove ribosomal sequences with quick align-
ment by Tophat2 [208]. Later, unmapped reads from above alignment were con-
verted into fastq file using bam2fastx [208]. Further, we constituted the consensus
sequence for Full length L1 elements by converting BED into FASTA format with use
of fastaFromBed [240]. Consensus sequence of full length L1 elements were aligned
to Ribo-seq reads (single-end 50bp) with the help of bowtie (v1.0.1) [202] by us-
ing the -best parameter retrieved for different conditions varying from proliferation,
pre-senescence and senescence. Normalized coverage for uniquely mapped file was
obtained with help of bamCoverage [257] for each condition. Further, matrix com-
putation was performed on the bigwig file of each condition by using computeMatrix
from [257].
2.12 Statistical analysis
Wilcoxon-Mann-Whitney test was used for analysis at transcriptional and transla-
tional level. P-value<0.05 were considered statistically significant.
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3.1 A computational web-based application for ac-
celerated analysis of NGS data
3.1.1 General purpose
NGS has provided different approaches in the fields of genomics, transcriptomics and
epigenomics which has resulted in solutions for complex biological problems. The
applications covered in high-throughput sequencing technologies provides answers
at different levels such as in DNase-seq, RNA-seq, ChIP-seq, ATAC-seq, Ribo-seq,
FAIRE-seq, Methyl-seq, Hi-C, and many others [258]. The gradual decline in se-
quencing cost has led to a massive increase in the amount of sequencing data. To
analyze sequencing data in a short period of time, it demands in carrying out appro-
priate solution. During the initial investigation of NGS datasets at transcriptional
and translational level, I inquired insight about a framework which can exclusively
relevant in-depth downstream analysis for NGS applications. Considering lack of
particular framework, I developed novel web-schema that follows the central dogma
process through which DNA information can be transformed into a functional prod-
uct such as protein. It pursues two phases of gene expression including transcription
and translation. The various applications of NGS technologies incorporated into our
RanchNGS web interface are ChIP-seq [171], RNA-seq [185, 186] and Ribo-seq [195,
198] (Figure 3.1). ChIP-seq illustrates DNA-protein interactions on genome-wide
scale. RNA sequencing utilizes the benefit of deep sequencing technologies to study
transcriptome profiling. Transcript identification and gene expression portray two
aspects of RNA sequencing. Ribosome profiling with the use of high-throughput se-
quencing helps to describe the ribosome footprints obtained after mRNA translation.
RanchNGS is introduced as a web application used to examine NGS technologies. In
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RanchNGS, RNA-seq and Ribo-seq section enables gene expression studies at tran-
scriptional and translational level. The essential fundamentals in the development of
web application include different aspects of data, algorithms, and asset of visualiza-
tions.
Figure 3.1: Schematic illustration of RanchNGS framework architecture.
3.1.2 Web interface framework
The RanchNGS essentially focuses on a downstream section of the NGS analysis.
In case of transcriptomics methods, it adopts RNA-Seq, for epigenomics methods it
adopts ChIP-seq and for ribosome profiling it adopts Ribo-seq. The starting section
of RanchNGS consists of a ChIP-seq analysis followed by an RNA-seq analysis and
then a Ribo-seq analysis. RanchNGS also comprises section for the integration of the
ChIP-seq and RNA-seq and the integration of the RNA-seq and Ribo-seq (Figure 3.1).
The benefit of integration for sequencing technique has proven to be advantageous in
deeper comprehension of gene regulatory mechanisms [259].
The RanchNGS utilizes mapped reads in BAM format as input for the RNA-seq
as well as for Ribo-seq analysis, whereas, for the ChIP-seq, ATAC-seq and DNA-seq
analysis input are required in the BED format, which can be obtained after peak
calling. In RanchNGS, data can be uploaded to a web interface for analysis in two
different ways: by using an upload button for smaller files and utilizing a file transfer
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Figure 3.2: Sample snapshot of RanchNGS web-application.
protocol (FTP) or hypertext transfer protocol (HTTP) link for larger files (Figure
3.2).
In RanchNGS, ChIP-seq analysis constitutes TFTargetCaller [260] for peak an-
notation. The scoring method in the TFTargetCaller [260] consists of three steps,
namely 1) peak-to-gene assignment 2) peak scoring and 3) integration of particular
peak scores. The TFTargetCaller utilizes several methods or algorithms to identify
the transcription factor (TF) targets. The primary characteristics of the closestGene
method include: 1) assigning peaks to the closest gene 2) scoring peaks and 3) the
summation of all peaks assigned to a given gene. The closestGene considers all peaks
that are 1 Mb upstream and 1 Mb downstream of the Transcription start-site (TSS)
[260]. Further annotated peaks are subjected to gene ontology analysis using bioMart
[261] package and for gene enrichment, RanchNGS applies ReactomePA [262]. The
ReactomePA provides pathway analysis based on Reactome pathway database. The
bioMart package uses specific databases for distinct species in evaluating gene ontol-
ogy. The ChIP-seq results consist of annotated peaks and lists of enriched genes that
can be obtained in a tabular format. In RNA-seq, RanchNGS uses featureCounts
to fulfill its requirement for counting of reads overlying with genomic features [248].
For the identification of differentially expressed genes, RanchNGS incorporates DE-
Seq2 [232] (Section 2.3.2). Moreover, for providing gene annotation it incorporates
bioMart [261] and for enriched pathway analysis, it applies ReactomePA [262]. The
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RNA-seq results analyzed using RanchNGS contains annotation of differentially ex-
pressed genes. Ribosomal profiling involves counting reads with particular genomic
features using featureCounts [248]. The differential gene expression for translational
regulation is analyzed with DESeq2 [232]. The downstream analysis of ribosomal
profiling data includes performing gene ontology using bioMart [261] and enrichment
pathway analysis using ReactomePA [262] to assess the translation information.
Table 3.1: Table representing algorithms implemented by RanchNGS.
3.1.3 Technical implementation
The RanchNGS is a standalone application for in-depth downstream analysis of DNA,
RNA, and protein data. The development of the web application was assigned in two
sections, in particular, front-end development and back-end development. The front-
end implementation of the RanchNGS web interface involves the use of hypertext
markup language (HTML), cascading style sheets (CSS) and javascript programming
language. The back-end implementation of the web application involves the integra-
tion of various languages such as R and perl into the existing hypertext pre-processor
(PHP) web programming language. The main function of the RanchNGS is to pro-
vide results in the form of PDF images, while detailed gene-related information can
be obtained in tabular format, with the possibility of directly downloading it to a
computer. The results and figures can be obtained accordingly without any further
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user action. Distinct selective measures were taken into account to apply particular
statistical R packages. The RanchNGS implements the relevant publicly available
statistical R packages.
3.1.4 Example section
To inspect the efficient use of our system. I have exhibited the example segment
of RanchNGS for each particular analysis with use of publicly available data. I
have uploaded the applied data in the demo section of our web-interface. All the
underneath figures in example section are acquired from RanchNGS.
3.1.4.1 Representation of ChIP-seq analysis
The ChIP-seq workflow involves the peak annotation using TFTargetCaller [260]
which is exclusive to RanchNGS. The other task for data processing in ChIP-seq in-
cludes gene-ontology (GO) and gene-enrichment. The ChIP-seq experiment enables
us to perceive broad knowledge about transcription-factors and histone-modifications.
The applied demo data for ChIP-seq is from publicly available source. The results
obtained from RanchNGS allows annotation of peaks to each particular gene, detail
information about GO terms and enriched pathway analysis (Figure 3.3B) 3.3C). The
demo datasets for ChIP-seq analysis have been collected from [263].
Figure 3.3: RanchNGS example segment for ChIP-seq analysis. (A) Plot interpreting
density distribution for called peaks. (B) Barplot describing the enriched pathways
by calculating p-value of it. (C) Dotplot representing the enriched pathways by
estimation of adjusted p-value.
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Figure 3.4: RanchNGS example segment for ChIP-seq analysis. (A) Table obtained
from RanchNGS for ChIP-seq analysis containing genesymbol, EnsemblID, Enterz-
geneID and GO terms. (B) Table characterizing EnsemblID along with its calculated
q-value for obtained peak.
3.1.4.2 Representation of RNA-seq analysis
The RNA-seq workflow includes the analysis of differential expression of genes for
transcriptional control. RNA-seq analysis in RanchNGS benefits from identifying
significantly differentially expressed genes. Genes with FC > 1 and adjusted p-value
< 5% were defined as differentially expressed genes. The results in RNA-seq consists of
plots and tables from downstream analysis (Figure 3.5)(Figure 3.6)(Figure 3.7)(Figure
3.8). The demo datasets for RNA-seq analysis have been collected from[247].
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Figure 3.5: RanchNGS example segment for RNA-seq analysis (A) MA plot retrieved
from RNA-seq datasets. In it, each dot equates towards particular gene. The x-axis
represents average expression of normalized counts for all samples, y-axis represents
log2 fold change for normalized counts between control and treatment. Genes defining
adjusted p-value less than 0.1 are shown in red. (B) Dispersion plot obtained from
RNA-seq datasets representing the dispersion estimates of each gene. In it, black
points shows the dispersion estimates of each gene individually. The blue points
exhibit true estimates of each gene. While blue points encircled are the dispersion
outliers. Red line marks the distinction between two categories.
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Figure 3.6: RanchNGS example segment for RNA-seq analysis (A) Heatmap ob-
tained from demo datasets for RNA-seq experiment demonstrating top 100 variance
genes for transcriptional regulation. Red color signifies the upregulation of genes and
blue color signifies downregulation of genes. The dendogram on the left side shows
the hierarchical clustering of the samples. (B) Volcano plot obtained from demo
datasets in RNA-seq representing gene expression results. The x-axis exhibits log2
fold change and y-axis exhibits –log10 of p-value. In it orange color points represent
log2FoldChange greater than 1, green points represent p adjusted value less than 0.05
and log2FoldChange greater than 1.
Figure 3.7: (A) Table acquired from RanchNGS for RNAseq analysis consisting of
differential expression values including log2 Fold-change(log2FC), p-value and ad-
justed p-value. (B) Table attained from the outcome of GO determination along with
gene-symbol and Enterzgene ID.
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Figure 3.8: RanchNGS example section for RNA-seq analysis (A) Bar-plot obtained
for enrichment results in RNA-seq datasets. Each colored bar represents enriched
pathways on basis of p-value. (B) Dot plot obtained for enriched pathways from
RNA-seq datasets. Each bar represents the enriched pathways on basis of adjusted
p-value.
3.1.4.3 Representation of Ribo-seq analysis
Ribosomal-profiling fulfills the divergence between RNA sequencing and proteomics.
The Ribo-seq workflow involves the analysis of deep sequencing of ribosomal profiling
data in the measurement of expression for translational control. It assists in charac-
terization of differentially translated genes. Quantitative analysis and visualization
are quite effective in analysis of ribosome footprints (Figure 3.9) (Figure 3.10). In
Volcano plot (Figure 3.9B), orange color points represent log2FC greater than 1, green
points represent adjusted p-value less than 0.05 and log2FC greater than 1. The demo
datasets for Ribo-seq analysis have been collected from [247].
70
Chapter 3. Results
Figure 3.9: RanchNGS example section for Ribo-seq analysis. (A) Principal com-
ponents analysis (PCA) plot inspecting the relationship between different conditions
(control and treatment) in Ribo-seq datasets. (B) Barplot obtained for enriched path-
ways dissection in Ribo-seq datasets. Each colored bar represents pathways on basis
of adjusted p-value.
Figure 3.10: RanchNGS example section for Ribo-seq analysis. (A) Heatmap obtained
from demo datasets in Ribo-seq experiment demonstrating top 100 variance genes
for translational regulation. The dendogram on the left side shows the hierarchical
clustering of the samples. (B) Volcano plot obtained from demo datasets in Ribo-seq
samples. The x-axis exhibits log2 fold change and y-axis exhibits –log10 of p-value.
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3.1.4.4 Illustration of integration for RNA-seq and Ribo-seq
The integration of RNA-seq and Ribo-seq can be useful in knowing insight about
genes involved in transcriptional as well as translational control (Figure 3.11).
Figure 3.11: RanchNGS example section of integration for RNA-seq and Ribo-seq
data. The x-axis depicts log2FC for RNA-seq data and y-axis depicts log2FC for Ribo-
seq data. Plot representing transcriptional and translational association. Dot marked
with red fill shows genes getting upregulated in RNA-seq are getting down-regulated
in Ribo-seq. Dot marked with green fill represents genes getting down-regulated in
RNA-seq as well as in Ribo-seq.
3.1.5 Characteristics of RanchNGS
The aim in designing RanchNGS web-tool was to make more user-friendly for the
“biologists.” RanchNGS is available as an open-source application. Moreover, Ranch-
NGS requires from robust hardware resources to achieve its task. It aids in a wide
range of NGS applications and contributes in automation of downstream analysis.
RanchNGS carries out analysis in the background and results can be obtained di-
rectly on completion of respective analysis. In addition, RanchNGS is not confined
to user’s operating system (Windows, macOS, linux). I have also applied the above
web-framework in an investigation for transcriptome analysis in the vicinity of L1
elements (Section 3.2).
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3.1.6 Comparison of RanchNGS to other web-interfaces
The characteristics of RanchNGS differs from other available web-interfaces in respect
to different criteria. The measure of computational analysis in RanchNGS is quite
uncomplicated to available web-interfaces. Among other platforms, Chip-enrich [264]
solely performs Chip-seq analysis whereas DEB [265] focuses particularly on RNA-
seq analysis. Galaxy platform however, performs tasks closely related to RanchNGS
application as it also executes different types of analysis in one platform. In iden-
tifying ribosome footprints, RiboProfiling (a Bioconductor package) focuses on the
quantification at the transcript level whereas, RanchNGS focuses on quantification
at the gene level. In contrast to other web-interfaces, our system supports reduced
computational time in analyzing either small or larger input files in comparison to
galaxy web-framework. Our system therefore enables users to obtain analysis results
in a reduced period. A novel approach in form of web-schema, RanchNGS system
provides the opportunity in performing integrative analysis of NGS techniques. An
overview of attributes of RanchNGS in comparison to other resources are mentioned
in (Table 3.2).
Table 3.2: Comparison of RanchNGS features to available web-interface systems.
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3.2 In silico dissection of L1 retrotransposons in
cellular senescence
3.2.1 General purpose
L1 elements are regarded as a major player in evolution, capable of causing diseases
to its host. In the human genome, p53 binding sites have been identified within L1
elements [36]. During the evolution of L1 elements, p53 have been shown to regulate
L1 activity by preventing L1 insertion. Hence, p53 is also referred to as guardian of
the genome [37]. In our study, I attempted to understand the consequences of p53
over-activation in immortalized cells transforming into senescent cells. To address
this, in-house developed web-framework (Section 3.1) for data characterization was
used during the initial evaluation. An additional frontier of defense in L1 elements
has been regulated by TRIM28 (also known as KAP1) at the transcriptional level
and mediated through APOBECs proteins at post-transcriptional level. Herein, I
re-analyzed RNA-seq and Ribo-seq datasets to confer the cross-talk of L1 and host-
defense machinery, while cells undergo senescent. APOBEC3B proteins were ad-
ministered in RNA editing mechanism by converting C to U base [127]. Moreover, I
inspected in-silico RNA editing pattern from APOBEC3B protein from immortalized
cells undergoing senescence.
L1 elements are responsible for the modification in chromosomal rearrangement
which could result in tumorigenesis [92]. If activity of L1 elements are not restrained
by host then it would result in L1 retrotransposition. Although L1 retrotransposition
activity can also be further associated with double-strand breaks (DSBs) during in-
tegration into genome [38, 199]. To investigate if L1 is undergoing retrotransposition
the genome was examined for new insertional events, by means of chimeric transcripts.
Furthermore, our hypothesis was based on to understand the role of L1 retrotrans-
posons in a probable mechanism of immortalized cells undergoing senescence, since
they are incapable of undergoing apoptosis (Figure ??).
3.2.2 Data characterization of senescent cells with cells of its
origin
RNA-seq reads were mapped to the human genome (hg19) using STAR [209] and
further subjected to quantification and expression analysis [Table 2.1]. I used our in-
house developed RanchNGS web-framework (Section 3.1) to obtain a diverse genome-
wide response in senescent cells along with cells of its origin (Figure 3.12). Primarily,
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I obtained a scatter-plot for log2foldchange and average of counts, which were nor-
malized by size factor. The red dot in a scatter-plot represents FDR of less than
5 % (Figure 3.12A). The PCA plot was plotted to visualize the variation between
different samples. It can be adopted as an approach in gathering quality control of
the data (Figure 3.12B). In addition, I also acquired dispersion plot which provides
the dispersion estimates for each gene. The genes represented by dots that are circled
blue have higher gene-estimates‘. The red line in the plot depicts samples are moving
toward final estimate (Figure 3.12C).
Figure 3.12: Data characterization of senescent cells with its cells of origin in im-
mortalized human primary BJ fibroblast cells. (A) MA plot shows the dependency
between the samples in terms of log fold change and mean of normalized counts. Dots
displayed in red implies if the adjusted p-value is less than 0.05 (B) PCA plot dis-
plays the sample-to-sample distances in terms of variation between expression analysis
samples (C) Dispersion plot represents the dispersion estimates for each gene. (D)
Heatmap exhibits Z-score (Spearman and Pearson correlation used for columns and
rows clustering) of top variance genes over different samples. In it, blue color illus-
trate down-regulation of genes. Whereas red color illustrate up-regulation of genes.
The above images are obtained from our developed ”RanchNGS” web-interface.
3.2.3 Gene expression transition during cellular senescence
The expression levels of genes in senescence and proliferation were compared. Genes
with Fold-change (FC) > 1 and False-discovery rate (FDR) < 5% were defined as
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differentially expressed genes. Out of 24,000 genes, 2874 genes were differentially ex-
pressed. I observed that genes such as BAK1 (BCL2 antagonist/killer 1), VGF (VGF
nerve growth factor inducible), CSF2 (Colony stimulating factor 2), TFEB (Tran-
scription factor EB), CCL3 (C-C motif chemokine ligand 3) and CDH10 (Cadherin
10) were upregulated in senescence while TRIM28, APOBEC3B, RAD21 (RAD21
Cohesion complex component), PRKDC (Protein kinase DNA-activated catalytic
polypeptide) and TP53 (Tumor protein p53) were downregulated in senescence (Fig-
ure 3.13A). Following GO analysis, cell cycle arrest term with a significantly high
p-value (p-value = 9.47e-59) in comparison to double-strand break repair followed
by DNA damage response, p53 signal transduction (p-value = 3.08e-06) and double-
strand break repair (p-value = 5.48e-14) were observed (Figure 3.13B) using differ-
entially expressed gene-list analysis in PANTHER.
Figure 3.13: Overview of downstream analysis for differentially expressed genes. (A)
Comparison of gene’s expression profile for senescence vs prolilferation. Genes men-
tioned in blue color are getting downregulated whereas genes mentioned in red color
are getting upregulated. (B) GO enrichment analysis of differentially expressed genes
in between senescence and proliferation.
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3.2.4 Down regulation of TRIM28 and APOBEC3B during
cellular senescence
TRIM28 (TRIpartate motif-containing protein 28), which is also described as
KAP1 (KRAB-associated protein 1) is a co-factor and it recruits ZFPs. KRABs
are known to exhibit various functions in Transcription and DNA repair [87, 266].
The APOBEC3B (apolipoprotein B mRNA editing enzyme 3) proteins are known to
constrain replication of endogenous retroviruses [267] Previous studies have demon-
strated the relationship between L1 expression and KRAB-KAP1 system [58]. The
APOBECs family of proteins have been shown to inhibit L1 retrotransposition [268–
271]. In this current study for immortalized human primary BJ fibroblast cells, the
results enlighten for the first time about the expression of TRIM28 was reduced in the
pre-senescent and senescent cells (decrease of 2-fold) when compared to proliferative
cells (Figure 3.14A). Moreover, the APOBEC3B was not expressed in senescent cells
but only expressed in the proliferative cells (Figure 3.14B).
Figure 3.14: (A) Downregulation of TRIM28/KAP1 determined during transition
from proliferative to senescent condition. (B) Downregulation of APOBEC3B mea-
sured during transition from proliferative to senescent condition.
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3.2.5 Up regulation of retrotransposable elements during cel-
lular senescence
To further investigate the role of L1 and Alu elements in the course of cells under-
going cellular senescence, RNA-seq data was used for analysis of retrotransposable
elements. Mapped RNA-seq reads were obtained after mapping to the human refer-
ence genome (hg19) using bowtie (v0.9.6) with specific parameters. Moreover, FPKM
values were estimated using Cuﬄinks (2.0.2). Expression analysis for conditions such
as proliferation, pre-senescence and senescence was carried out from mapped RNA-seq
reads for L1 and Alu elements. The expression profile of L1 elements associated with
different cell conditions showed significantly upregulated expression levels for cells in
senescence when compared to those proliferating (p-value = 2.2e-16) (Figure 3.15).
However, some genes belonging to L1 subfamily, such as L1PA5 and L1PA7, were
upregulated in proliferating cells (Figure A.2). To confirm the reactivation of TEs
during cellular senescence, the same analysis was performed for Alu element subfam-
ilies (mainly Alu J, Alu S, and Alu Y) forming part of SINEs class of retrotranspos-
able elements. Expression of AluJ subfamily was significantly upregulated (p-value
= 2.2e-16) during senescence cells in comparison to proliferating cells(Figure 3.16).
Moreover, the gene expression of AluS and AluY subfamilies also showed significant
upregulation in senescence cells (p-value = 2.2e-16). Alu and L1 retrotransposition
are both involved in gene insertions [68]. Due to the dependence of Alu’s transposi-
tion elements on L1 ORF2p, Alu elements are known to cause a number of diseases
as compared to L1 by means of insertions [101].
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Figure 3.15: Expression analysis for L1 elements. Gene expression profile of L1
elements showed significant up-regulation in senescence condition as compare to other
conditions (p-value = 2.2e-16). The statistical significance of expression difference was
calculated using Wilcoxon-Mann-Whitney test
Figure 3.16: Expression analysis in different families of Alu elements. (A) In AluJ
family of elements it exhibited significant up-regulation in senescent cells. (B) In AluS
family of elements it showed significant upregulation of expression in senescent cells.
(C) For AluY family of elements also showed significant upregulation in expression
for senescent cells (p-value = 2.2e-16). The p-value was calculated using Wilcoxon-
Mann-Whitney test
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3.2.6 Confirmation of L1 encoded proteins at translational
level
To further corroborate L1 activity during cellular senescence, ribosomal profiling
(Ribo-seq) data obtained from immortalized human primary BJ fibroblast cells in
different conditions was re-analyzed. L1 elements consist of two open reading frame
proteins (ORF1p and ORF2p). ORF1p encodes RNA binding protein, which has a
function in nucleic acid Chaperone activity. ORF2p consists of endonuclease and re-
verse transcriptase activities that are a required for L1 retrotransposition [272–274].
Before mapping, adapter and ribosomal RNA (rRNA) sequences were removed to
ensure efficient downstream analysis. After mapping, normalized coverage by using
bamCoverage [257] was attained. In addition, average normalized coverage in locus of
L1 elements for each particular condition was plotted. Interestingly, significant trans-
lation of L1 open reading frames (ORFs) in ribo-seq repertoire in senescent cells was
observed when compared to immortalized ones (p-value = 2.2e-16). (Figure 3.17).
Figure 3.17: Comparative overview of L1 coding transcripts in ribo-seq repository.
(A) Heatmap exhibiting the enrichment in senescence as compare to proliferation. (B)
Coverage-plot demonstrating the enrichment in senescence as compare to prolifera-
tion. (C) Identification of significant level of mapped reads for L1-coding transcripts
in ribo-seq repertoire (p-value = 2.2e-16). The statistical significance for L1 coding
transcripts was calculated using Wilcoxon-Mann-Whitney test
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3.2.7 RNA-editing role from APOBEC3B protein in regula-
tion of L1 retrotransposition control
In contemplation of APOBECs group of proteins performing RNA editing function
aimed at inhibiting L1 retrotransposition [270], profiling of RNA-seq data was used
for detecting RNA editing sites. In RNA editing analysis, firstly the variant calling
approach was applied for the identification of SNPs from RNA-seq data obtained
from immortalized human primary fibroblast cells. Subsequently, mismatches at read
ends were filtered to avoid false positives and sequencing error and this was followed
by filtration based on full-length of L1 elements to determine RNA editing sites.
Upon further analysis of RNA-seq data, 56020 editing sites in proliferative and 48325
editing sites in senescent cells were obtained before filtrating repetitive elements.
326 editing sites for proliferative and 316 editing sites for senescent were obtained
following filtration of repetitive elements. In RNA editing analysis, we observed
the differential pattern of RNA editing for ADAR as well as for APOBEC3B in
proliferative and senescent cells in loci of full-length L1 elements (Figure 3.18). The
RNA editing pattern for ADAR and APOBEC3B in loci L1 elements which are not
capable of jumping was further investigated (Figure 3.18A and C). The distribution
of differential RNA editing for the youngest L1 subfamilies (L1Hs, L1PA2, L1PA3)
which are capable of retrotransposition in the cells undergoing senescence for ADAR
(Figure 3.18B) as positive control against RNA editing pattern for APOBEC3B gene
was observed. Interestingly, significant differential RNA editing for APOBEC3B gene
in loci of youngest L1 lineages (p-value = 0.02403) for cells undergoing senescence
was also observed. (Figure 3.18D). Furthermore, in-silico motif pattern which were
executed as a way of validating RNA editing in L1 elements using MEME-suite was
also established. The RNA editing analysis demonstrated an association of APOBECs
or ADAR RNA editing in L1 elements as shown in (Figure 3.20).
During the past 40 miliion years (Myrs), L1 subfamilies have evolved in a promi-
nent way along primate lineage initiating in humans lineage [84, 275]. The rise in the
number of RNA editing sites in the senescent state for the middle-aged L1 subfamilies
as compare to the youngest L1 subfamilies was also revealed (Figure 3.19). Moreover,
a pattern in the number of RNA editing sites in proliferative state for L1 element
subfamilies was also established (Figure A.3).
81
3.2. In silico dissection of L1 retrotransposons in cellular senescence
Figure 3.18: Differential RNA editing profiling of ADAR and APOBEC3B on loci of
L1 families in the cells sustaining senescence. The blue-bordered color implies dis-
tribution of proliferative cells, whereas the red-bordered color implies distribution of
senescent cells. (A) Differential RNA editing pattern for ADAR gene in loci of ancient
and middle-aged L1 subfamilies. (B) Differential RNA editing for ADAR gene in loci
of L1 elements capable of transposition. (C) Differential RNA editing for APOBEC3B
gene in loci of ancient and middle-aged L1 subfamilies. (D) Differential RNA editing
for APOBEC3B in loci of youngest L1 elements (L1Hs,L1PA2 and L1PA3) which are
capable of transposition (p-value = 0.02403). The statistical significance in editing
frequency was calculated using Wilcoxon-Mann-Whitney test.
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Figure 3.19: Distribution of RNA editing sites for entire L1 families. The first quarter
represents youngest L1 subfamilies which are 3 Myr ago. The second quarter repre-
sents middle-aged L1 subfamilies which are 20 Myr ago. The third quarter represents
ancient L1 subfamilies which are 35 Myr ago.
Figure 3.20: De novo motif analysis for RNA editing sites in loci of L1 elements. It
specifies top hit retrieved for motif distribution.
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3.2.8 Specification of insertional events using chimeric tran-
scripts design
Considering that L1 is involved in retrotransposition, then the genome is likely to
have new insertions. Herein, a recently developed novel approach to predict new
insertional events was adopted. By using our in-house developed pipeline, a diverse
pattern of chimeric transcript between the full-length L1 elements and genomic re-
gions in senescent cells compared with proliferative ones was observed. Chimeric tran-
scripts are known to form as a result of gene fusion [276]. In L1 elements chimeras are
formed during L1 integration mechanism [277]. Circos plot representing the pattern
for proliferative cells from acceptor sites showed 0 chimeric transcripts (Figure 3.21A).
Moreover, the pattern for cells entering senescent state demonstrated 4 chimeric tran-
scripts (Figure 3.21B). Noticeably, chimeric transcripts are enriched in senescent cells
as compare to proliferative cells. The link lines in circos plot (Figure 3.21) for the
fusion transcripts shows the relationship between two chromosomes for a specific con-
dition in loci of L1 elements. The chimeric transcript analysis was also performed for
proliferative and senescent cells from donor sites (Figure A.1). The circos plots for
donor as well as for acceptor splice sites showed a different distribution pattern in
immortalized human primary BJ fibroblast cell-type undergoing senescence (Figure
3.21)(Figure A.1). In our study, de novo a motif pattern from the above chimeric
transcripts formed between junction of full-length L1 elements and specified partic-
ular condition from immortalized human primary BJ fibroblast cells was observed.
L1 mediated insertion can cause disruption in target gene expression and function.
During L1 retrotransposition, ORF2p enclosing endonuclease activity is liable for
creating a nick on DNA at an insertion site. However, the motif pattern from our
chimeric RNAs for acceptor sites were compared with consensus sequence specified
for target site duplications (TSDs) acquired from The Cancer Genome Atlas [278].
Moreover, the consensus sequence of chimeric RNAs for proliferative and senescent
cells, uniquely for donor splice sites were also compared with consensus sequence of
TSDs (Figure A.4). Strikingly, in juxtaposition of motif comparison shows the pres-
ence of splice site with (p-value = 3.10e-02) and (E-value = 3.10e-02), thus predicting
new insertional event in cells undergoing senescence (Figure 3.22).
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Figure 3.21: Chimeric RNA transcript representation in immortalized human primary
BJ fibroblast cells for L1 elements capable of jumping (A) Circos plot illustration of
chromosome interactions for proliferative cells exhibited 0 chimeric transcripts. (B)
Analytical circos plot representation of chromosome interactions for senescent cells
exhibited 4 chimeric transcripts.
Figure 3.22: De novo motif analysis for insertional event of L1 elements from chimeric
acceptor sites. Target represents consensus sequence of chimeric RNAs found in
senescent cells. While query motif pattern displayed on left side represents consensus
sequence of TSDs. The statistical significance of motif comparison was calculated
using Tomtom (p-value = 3.10e-02).
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4.1 Web-based framework for high-throughput se-
quencing data analytics
Downstream data analysis plays a crucial role in retrieving detailed information from
any type of data. Therefore, in order to achieve this task, our novel web-interface
linked to applied Next-generation sequencing (NGS) applications, titled “Ranch-
NGS”, for downstream and integrative analysis of ChIP-seq, RNA-seq and Ribo-seq
data (Section 3.1), will be of distinct importance (Figure 3.1). Chromatin immuno-
precipitation combined with extensive next generation sequencing (ChIP-seq) tech-
nology has been associated with genome-wide profiling of protein-DNA interactions of
TFs and histone modifications. In cases of ChIP-seq data analysis, after mapping of
sequenced reads onto a reference genome, enriched regions are determined using avail-
able peak detection methods. The developed web-framework is based on downstream
analysis of ChIP-seq data, including peak annotation and gene enrichment. In partic-
ular, RanchNGS implements the TFTargetCaller [260] method for peak annotation
and respective R packages like bioMart for gene ontology and ReactomePA for gene
enrichment analysis. RNA-seq allows for an elaborative study of the transcriptome.
In cases of RNA-seq data, the analysis also includes an estimation of differential gene
expression and is effective in determining novel gene networks. In addition, for RNA-
seq, RanchNGS enables downstream data analysis for the evaluation of ontology and
analysis of enrichment of differentially expressed genes.
The translational process is an essential and coordinated step in gene expression.
To attain translation, the ribosome profiling approach was proposed. It consists of
deep sequencing of ribosome protected mRNA fragments. Ribosomal profiling has
been previously used in identifying translated ORFs [246]. Therefore, an integra-
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tion of RNA-seq and Ribo-seq data can be effective in investigating whether a tran-
scribed gene will be translated or not. Publicly available datasets were used in our
web-interface to inspect the outcome of Chip-seq, RNA-seq and Ribo-seq analysis.
RanchNGS results are displayed as different enrichment plots showing visualization
of differentially expressed genes and tabular information about p-values and adjusted
p-values, FC, EntrezID, EnsemblID, and GO-terms for further investigation. We
have demonstrated vital representation for every section with usage of demo datasets
(Section 3.1.4). RanchNGS was constructed to carry out integration of different
data types. RanchNGS allows for the analysis of diverse species, particularly human,
mouse, c.elegans and yeast. RanchNGS uses different programming languages in its
static framework for downstream analysis. During the development of the RanchNGS
web-interface, HTML and CSS have been used to build a convenient web-based user
interface. PHP along with the perl language has been integrated into the web appli-
cation to allow the user to upload data and to enable interaction with the server for
analysis. RanchNGS has the ability to upload the files in two forms; either by using
the upload button or by providing the URL through the FTP/HTTP link. Ranch-
NGS has been developed to also ensure the user’s data security and data privacy. The
main characteristics of RanchNGS in comparison to available NGS web applications
is that it performs the downstream analysis for each respective section by focusing on
the information directed from DNA to RNA and to form protein in a more direct way.
RanchNGS is quite easy to access and use by biological researchers. It is available as
open-source, along with its user manual.
NGS development has administered many fundamental aspects of genomics re-
search. NGS technologies consist of a vast number of NGS applications which I have
discussed in my introduction section of the thesis such as ChIP-seq, RNA-seq and
Ribo-seq [279]. Before the onset of sequencing, chromatin immunoprecipitation in
combination with microarrays techniques (ChIP-chip) [280] were widely used in de-
termining protein-DNA interactions on a genome-wide scale range. Chromatin open
assay techniques, namely DNase-seq, FAIRE-seq and genome-wide DNaseI footprint-
ing, are currently considered as substitutes for chromatin immunoprecipitation [281].
Another method, named chromosome conformation capture (3C), determines areas
of DNA carried forward by the nucleus, also known as looping [180]. In gene expres-
sion studies, RNA-seq serves to gain in-depth knowledge about whole transcriptomes.
RNA-seq does not have any of the drawbacks of microarray technology. To remove
technical bias, an appropriate normalization method must be applied prior to the
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comparison of expression levels between different conditions [282]. The primary ap-
plications of RNA-seq include detection of splicing, gene-fusions and RNA editing
[283]. RNA attached to ribosomes are represented as ribosome footprinting and se-
quencing performed on short fragments of RNA is referred to as ribosome profiling
(Ribo-seq) [195, 198, 284].
4.2 Regulation of host-defence genes against L1
retrotransposons at the transcriptional and
post-transcriptional level
I have re-analysed RNA-seq and Ribo-seq datasets from immortalized human primary
BJ fibroblast cells to confirm the presence of cross-talk between the L1 elements and
its host-defence machinery while the cells undergo senescence (Section 3.2). In brief,
to obtain the transcriptome-wide gene expression response for our datasets, I used the
in-house developed “RanchNGS” web-framework. During transcriptome-wide inves-
tigation in our datasets, genes like BAK1 related to induce apoptosis, CDH10 linked
to colorectal cancer, CSF2 related to AML, CCL3 related to HIV-1 were upregulated
during transition from proliferation to senescence (Figure 3.13A). Consequently, in
GO analysis, terms like cell cycle arrest, DNA damage response and DNA double-
strand break repair were retrieved with highly significant p-values (Figure 3.13B).
Since TRIM28 and APOBEC3B play a crucial role in the regulation of L1 retrotrans-
posons and in our datasets it showed downregulation in cells undergoing senescence
(Figure 4.1A). TRIM28 and APOBEC3B genes are essential constituent in regulation
of host. In every L1 subfamily, TRIM28 recruits in particular the KRAB-ZFP protein
to repress the L1 element. Timely mutation over the course of the repression mecha-
nism makes the L1 sequence inactive, which results in no requirement for KRAB-ZFP
binding. L1 can then acquire necessary mutations to get it to be transcribed. To in-
hibit expression of the L1 element, the host forms another copy of KRAB-ZFP to
repress the newly transcribed L1 elements. This arms race then continues during
which TRIM28 has been involved in repressing the L1 elements by recruiting the hi-
stone methlytransferase SETDB1 complex that controls trimethylation of histone H3
on lysine 9 on chromatin [87, 114]. TRIM28 are also known to play an essential role
in DNA repair. While in DDR, TRIM28 gets phosphorylated upon ATM activation
[266]. If L1 breaks the cage of the transcriptional repression machinery, then PIWI-
interacting RNA (piRNAs) are able to degrade the L1 elements. Moreover, apart
from DNA methylation, piRNAs are well-known to control L1 elements in germ cells
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[285]. Recent findings have shown that piRNAs regulates L1Hs in early embryonic
stem cells [58]. Moreover, post-transcriptionally, another line of defence mechanisms
involved in the silencing of the L1 element is illustrated by the APOBECs group
of RNA editing proteins that have demonstrated an interaction with the L1 ORF1
protein [271].
4.3 Activation of L1 elements during cellular senes-
cence
Previous studies have shown that p53 tends to activate or repress L1 transcription,
due to the presence of p53 DNA binding sites inside L1 elements [37] and p53 has been
proven to be involved in inhibition of L1 mobility [36]. Therefore,p53 is also known as
a guardian of the genome. The different types of stress that lead to cellular senescence
include telomere erosion, oxidative stress, oncogene activation and DSBs [12, 14]. All
other forms of stress, namely chemotherapy, IR, and activated oncogenes may share
a common mediator of DNA damage in stimulating senescence [286, 287]. Upon
oncogenic stress induction the RASG12V gene causes diversification during cellular
senescence (Figure1.12).
TEs were analysed for the presence of a class of non-LTR retrotransposons to au-
thenticate the transformation during senescence. In the case of L1 retrotransposons,
significant upregulation of L1 transcription in the pre-senescent state that progressed
until the senescent state was observed (Figure 3.15). Another class of non-LTR retro-
transposons, namely Alu elements, are non-autonomous elements and are known to
use L1 machinery to be mobilized (Figure 4.1B). L1 elements provide endonuclease
and reverse transcriptase activities for the mobilization of Alu elements. I noticed
a significant transcriptional pattern for the younger Alu subfamily through the pre-
senescent state that progressed towards the senescent state. In combination, these
findings indicate that L1 activation might be a consequence of the deactivation of
host-defence genes, which control them. To further validate this hypothesis about
the acquired transcriptional L1 activity during senescence, translational activity in
the L1-encoded proteins was investigated (Figure 4.1C). Interestingly, I detected a
significant number of L1-encoded transcripts in the Ribo-seq repository for immor-
talized cells undergoing senescence (Figure 3.17). L1 ORF1 encodes RNA binding
protein and is considered to be a tumor-specific antigen. ORF1 has been linked to
p53 mutation in lung cancers [278, 288]. ORF2 encodes for both endonuclease and
reverse transcriptase activities, and both are necessary for L1 retrotransposition [272,
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289–291], and the endonuclease activity of L1 ORF2 is responsible for initiating DSBs
and causing DNA damage response (DDR) stimulation [292, 293].
4.4 RNA editing regulation in L1 mediated ma-
chinery
In our study, at the post-transcriptional level, the APOBEC3B gene showed dimin-
ishing regulation over L1 elements during cellular senescence. Cytidine deaminase is
known for performing RNA editing in the APOBECs protein family from cytidine
(C) to uridine (U) [140, 294] in order to safeguard our host genome against external
pathogens. Furthermore, I investigated the in-silico RNA editing pattern for ADAR
as well as for APOBEC3B enzymes in loci of ancient and middle-aged L1 subfamilies,
and I noticed a significant differential pattern of RNA editing in the youngest L1
subfamily for proliferative cells undergoing senescence in the loci of full-length L1 ele-
ments (Figure 4.1D). The youngest L1 lineages that are capable of retrotransposition
are L1Hs, L1PA2, and L1PA3. RNA editing has been found to be a phenomenon
necessary in organisms for regulation of gene expression [295]. RNA editing includes
two types of single-base modifications like cytidine (C) to uridine (U) and adenosine
(A) to inosine (I) deaminations [128]. Moreover, there are two types of RNA editing
enzymes, namely cytidine deaminase and adenosine deaminase, which play a crucial
role in recoding RNA sequence modifications [238]. Primarily, adenosine deaminases
acting on RNA (ADAR) are associated with the conversion of adenosine (A) to in-
osines (I) in double-stranded RNAs [296]. In contrast, there are eight orthologues of
the APOBECs family in humans [297]. The APOBEC3G gene has been observed to
act in defence against retroviral activity by HIV-1 strains [132, 298] and APOBEC3B
is established to be upregulated in around half of human cancers [299]. Interestingly,
I observed de novo a motif pattern associated with a differential RNA editing event
in the full-length L1 elements. This might indicate an affiliation to APOBECs or the
ADAR gene. Certainly, the specified line of evidence including a significant pattern
of L1-encoded transcripts and the observed differential RNA editing pattern in cells
undergoing cellular senescence suggest that it might be a result of the deactivation of
the APOBEC3B gene. The APOBEC3B gene component of the APOBECs protein
family has displayed critical functions in inhibition of L1 retrotransposons during
primate evolution [298].
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4.5 Blueprint of insertional events in L1 elements
by utilizing chimeric transcripts formation
L1 retrotransposons tend to move inside the genome through a “copy and paste”
mechanism. In the course of this event, the L1 element gets shoved out of its original
position and integrates into a new position [92]. At the time of integration, the L1
element can interrupt the function of host genes in numerous ways. For example,
an L1 element inserted in the coding part of a gene can disrupt the protein coding
function and if inserted in an upstream segment of a gene it can disturb the regula-
tory sequences [151]. The L1 retrotransposition plays an important role in causing
DNA damage in the human genome, which has not been thoroughly studied. Herein,
I adopted a novel approach to predict L1 insertional events in association with ge-
nomic regions within the process of L1 retrotransposition (Figure 4.1E). By using
our in-house pipeline, I detected a chimeric RNA transcript formed between the full-
length L1 element and genomic regions. In the L1 retrotransposition machinery, the
L1 RNA are transcribed and exported to the cytoplasm. In the cytoplasm, they get
translated into two ORFs proteins and contribute to the formation of ribonucleopro-
tein (RNP) complexes. ORF1p encodes for RNA binding protein and ORF2p encodes
for endonuclease as well for reverse transcriptase activities. The endonuclease (EN)
activity of ORF2 creates gaps at L1 insertion sites generating DSBs [292, 300]. The
reverse transcriptase activity (RT) is also responsible for establishing the L1 retro-
transposition [301]. During the process of target primed-reverse transcription, the
endonuclease function of ORF2p cleaves the 3’OH of the insertion site for priming
and then the RT function extends the strand to be used as a template. Rectification
of the double-stranded break requires the host DNA repair proteins. Failure of DNA
repair leads to insertional mutagenesis [102, 278]. In somatic cells, retrotransposi-
tions in Alu elements occur very few times [278, 302, 303]. In the course of germline
projection, retrotransposition in Alu elements is higher than in L1 [291]. In L1, over-
expression of the ORF1 protein has been considered to be an indication of human
cancers [291]. L1 retrotransposition contribute about 0˜.3% of human mutations [40].
L1 retrotransposition has been known to cause disease mutations in humans through
insertional mutagenesis [108]. There are numerous consequences of L1 mediated inser-
tions, which include disturbances in target gene expression and function [79]. It total,
124 insertions have been identified as causing genetic disease from germline-mediated
L1 retrotransposition [304].However, L1 insertions in somatic cells have also been de-
tected in colon cancer [91]. L1s retrotransposons can be a source of insertions and
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deletions during the retrotransposition process [92]. In our investigation, the ratio of
chimeric transcripts for cells undergoing senescence were higher in comparison to pro-
liferative ones (Figure A.4). Uniquely, motifs retrieved from de novo junction of L1
and genomic sequences were enriched in comparison to existing TSDs with a signifi-
cant p-value, suggesting a new insertional event in cells undergoing senescence. Since
L1 activity can contribute to DSBs during integration into the genome, these novel
insights provide consequences of oncogenic stress in proliferative cells that might be
related to L1 retrotransposition, thereby triggering DSBs and enabling cells to enter
senescence.
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Figure 4.1: A schematic representation of working development model.
4.6 Outlook
In this thesis, NGS technologies have been widely studied, and these include ChIP-seq,
RNA-seq, and Ribo-seq. DNA methylation is considered to be one of the mainstream
methods of epigenetic modification, and others include transcription, chromatin struc-
ture, embryonic development, and genome imprinting [305]. Gene expression is stud-
ied as one of the essential mechanisms in transcriptomics. The RNA-seq method is
used to measure the expression of genes, while the Ribo-seq method is used to de-
termine the translational abundance of gene products. RNA-seq is not only confined
to measuring gene expression but is also applicable in mutation analysis, fusion tran-
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script and alternative splicing detection [306]. Alternative splicing has been linked to
several inherited diseases [307].
TEs activity exhibits an interconnection between cancer and aging. In the area
of cancer research, L1 elements insertions have proven to be of high significance. The
first somatic L1 insertion was detected in the APC gene. In association with aging, L1
activity has demonstrated a diverse role. It has been reported that the extent of L1
retrotransposition in cancer increases vastly with age. In another study corroborating
these findings, in humans, TEs epigenetic silencing was shown to decrease with age
[308]. A comprehensive association between TEs and aging is a wide and promising
area of research.
4.7 Future work
Due to a huge reduction in the cost of genome sequencing, the number of NGS
applications has increased. NGS techniques have been used in all types of species
and are beneficial to any component of the genome. NGS techniques have helped
in bridging the gap between the research and diagnostics field [309]. Sequencing
technologies help pathologists in providing personalized medicine [310]. Moreover,
diverse NGS applications have been executed in clinical diagnostics [311, 312] and
NGS has been considered an effective tool in discovering causes and solutions for rare
diseases. A huge shift has been witnessed in transcriptomics sequencing from “bulk”
RNA-seq to “single”-cell RNA-seq (scRNA-seq). scRNA-seq has the potential to dis-
close complete new cell types. The drawback of using bulk RNA-seq in analysing
heterogeneous systems such as early embryonic development and brain system can
be prevented by using scRNA-seq. Cloud computing services have been adopted by
data researchers to provide benefits in medical innovations. However, the drawbacks
from second generation technologies prevail during the development into third gen-
eration technology. The third generation sequencing technology such as the PacBio
RS system (Pacific biosciences) and nanopore sequencing technology provide longer
read lengths of about 5500–8500 bp [313]. Long reads have exhibited better charac-
terization in studying the interaction between structural nuclear variants (SNV) and
copy number variant (CNV) in virus populations. Several NGS applications have
generated enormous amount of data, thus posing challenges in the storage of such
big data sets. Collectively, the above mentioned aspects constitute the extensive re-
quirement for computational and data storage infrastructure [314]. Hence, with the
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advanced growth in NGS technologies, it is necessary to address major challenges of
data storage, security, data analysis and integration.
In the past era, TEs have provided beneficial outcomes for the scientific com-
munity in terms of health and disease. It has been proven TEs are more than just
“junk” elements. In relation to cross-species analysis, it has shown the evolutionary
modifications between the human and non-human primate genome. In addition to
the extensive development of the sequencing technology, longer read sequencing will
be highly advantageous in examining repetitive regions. In a recently published re-
search article, by using whole-genome sequencing with the support from the PacBio
sequencer, they were able to detect candidates for somatic L1 insertions in human
colon cancer [91]. Longer reads are quite essential to characterize the interactions
between SNV and CNV in emerging viral populations. Furthermore, there are nu-
merous TEs families that are currently active and capable of transposition inside
human genomes such as HERV-K, L1, Alu, and SVA elements. Previous studies have
reported a vast number of diseases linked to active non-LTR retrotransposons such
as haemophilia, leukaemia, breast and colon cancer [39]. A Contempo research pub-
lished recently showed the involvement of a distinct set of genes in L1 regulation by
using CRISPR-Cas9, an approach for genome-wide DNA editing [315]. In future, an
investigation is required to retrieve L1-mediated retrotransposition events in germline
and somatic cells [54].
Furthermore, in future, it would be intriguing to study the role of TEs in cellular
senescence at the scRNA-seq level using longer sequence reads from PacBio.
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The advancement in the field of high-throughput sequencing technologies has funda-
mentally transformed biological research. Due to reduction in the cost of sequencing,
the number of sequenced genomes from human and diverse other species has been
raised considerably. The establishment of sequencing technology has constituted vast
amount of manifold NGS applications. During the exploration of NGS datasets at
transcriptional and translational level, we pursued enlightenment about a framework
which can entirely pertinent to NGS applications. Therefore, we aim to create a soft-
ware framework, which is entirely pertinent for analysis and integration of data from
several NGS applications. These include characterization of transcriptomes by RNA-
seq, determination of ribosome profiling by Ribo-seq and genome-wide identification
of protein-DNA interactions by ChIP-seq. Hence, I developed a web application
(RanchNGS) for downstream and integrative analysis of the corresponding data. Be-
sides particular individual analysis, RanchNGS also attains to illuminate biological
coherances by means of data integration. Currently RanchNGS can be used to analyse
data from human, mouse, c.elegans and yeast. I have utilized publicly available tools
in my web interface. The biggest challenges of NGS applications are data storage and
analysis. RanchNGS is highly efficient and particularly beneficial for the life-science
community, because it can be used without any software-coding skills. In this thesis
I have focused on the development of computational programs for detailed analysis
of data obtained from RNA-seq and Ribo-seq experiments. I have also demonstrated
the performance of the entire established RanchNGS web-framework at length using
datasets from experiments about cellular aging (senescence).
Aberrant expression of oncogenes can induce cellular responses like senescence or
apoptosis. Oncogenic stress has been known to play a vital role in the induction of
DNA damage response by restraining a mechanism of oncogene-induced senescence
(OIS). Herein, I sought to understand the result of excessive oncogenic stress by
targeting p53 in immortalized cells. p53 has been known to safeguard the activity
of L1 elements in the genome by preventing L1 insertions. L1 activity is known to
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be constrained transcriptionally by TRIM28. While in case of evasion, APOBECs
group of enzymes regulate L1 activity by RNA editing machinery. In novel finding,
downregulation of TRIM28 and APOBEC3B during senescent state was observed
indicating depletion of regulation in L1 elements. Interestingly, L1 elements were up-
regulated in cells undergoing senescence. Possibly, reactivation of L1 elements might
be a result of deactivation of host-defense genes (TRIM28 and APOBEC3B) which
control regulation of L1 elements. To eliminate the possible illusion of false alarm
at transcriptional level, I inspected the translational pattern of L1 ORFs in Ribo-seq
domain. In relation to post-transcriptional analysis, I detected a significant pattern of
L1 coding transcripts in the cells undergoing senescence. Probably, this observation
might be explained due to the deactivation of RNA editing enzymes. Furthermore, I
inspected in silico RNA editing events for ADAR as well as APOBEC3B enzymes in
ancient and middle-aged L1 subfamilies. A significant differential RNA editing pat-
tern was observed through the action of APOBEC3B enzyme between proliferative
and senescent cells in loci of youngest L1 elements which are capable of jumping. If
the nick in DNA is above a certain threshold, L1 elements generate insertions and
constitute double-strand breaks (DSBs) during integration into the genome. I de-
tected the insertional event by means of chimeric transcripts between L1 elements
and genomic regions. Curiously, the motif for target site duplications (TSDs) was
enriched at the de novo junction of L1 elements and genomic sequence indicated new
insertions in senescent cells. Interestingly, our results suggest that excessive oncogenic
stress in immortalized cells might be linked to L1 jumping, thereby inducing DSBs
and enabling cells to enter into cellular senescence.
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Die Fortschritte im Bereich der Hochdurchsatz-Sequenzierverfahren haben die bi-
ologische Forschung grundlegend gewandelt. Infolge der Reduzierung der Sequen-
zierungskosten hat sich die Zahl der sequenzierten Genome der humanen und ver-
schiedener anderer Spezies deutlich erho¨ht. Die Etablierung der Sequenziertech-
nologie hat eine enorme Anzahl vielfa¨ltiger NGS-Anwendungen hervorgebracht.
Bei der Analyse von NGS-Datensa¨tzen auf transkriptioneller und translationaler
Ebene suchten wir nach einem universellen Rahmen, der fu¨r viele verschiedene
NGS-Anwendungen genutzt werden kann. Wir wollten ein Software-Framework
erstellen, das fu¨r die Auswertung und Integration von Daten aus verschiedenen
NGS-Anwendungen von großem Nutzen ist. Dazu za¨hlen die Charakterisierung
von Transkriptomen mit RNA-Seq, die Bestimmung von Ribosomen-Profilen mit
Ribo-Seq und die genomweite Identifikation von Protein-DNA-Interaktionen mit
ChIP-Seq. Demzufolge habe ich eine Web-Applikation (RanchNGS) fu¨r die Ve-
rarbeitung und integrative Analyse entsprechender Daten entwickelt. Abgesehen
von spezifischen einzelnen Analysen zielt RanchNGS auch darauf ab, biologische
Zusammenha¨nge durch Integration von Daten zu erhellen. Derzeit kann RanchNGS
zur Analyse von Daten aus Mensch, Maus, C.elegans und Hefe verwendet wer-
den. Ich habe in meinem Web-Interface o¨ffentlich verfu¨gbare Programme verwendet.
Die gro¨ßten Herausforderungen der NGS-Anwendungen sind die Daten-Speicherung
und –Analyse. RanchNGS arbeitet sehr effizient und ist besonders nu¨tzlich fu¨r die
Life-Science-Gemeinde, da es auch ohne Programmierfa¨higkeiten genutzt werden
kann. In dieser Doktorarbeit habe ich mich auf die Entwicklung von Rechenpro-
grammen fu¨r die detaillierte Analyse von Daten konzentriert, die aus RNA-Seq- und
Ribo-Seq-Experimenten gewonnen wurden. Die Leistungsfa¨higkeit des umfangre-
ichen RanchNGS-Web-Frameworks habe ich ausfu¨hrlich anhand von Datensa¨tzen aus
Experimenten zur zellula¨ren Alterung (Seneszenz) demonstriert.
Die anomale Expression von Onkogenen kann zellula¨re Reaktionen wie Seneszenz
oder Apoptose hervorrufen. Es ist bekannt, dass onkogener Stress eine entschei-
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dende Rolle bei der Induktion von Reaktionen auf Scha¨den der DNA durch Un-
terdru¨ckung von onkogen-induzierter Seneszenz (OIS) spielt. Hier habe ich versucht,
die Folgen von exzessivem onkogenen Stress auf das Target p53 in immortalisierten
Zellen zu verstehen. Es ist bekannt, dass p53 die Aktivita¨t von L1-Elementen im
Genom kontrolliert, indem es Insertionen von L1 unterbindet. Man weiß, dass
die Aktivita¨t von L1 transkriptionell durch TRIM28 gehemmt wird, wohingegen
im Fall der Umgehung, die APOBEC-Enzymgruppe die L1-Aktivita¨t durch den
RNA-Editierungsmechanismus steuert. Als neuen Befund konnte ich eine Herabreg-
ulierung von TRIM28 und APOBEC3B im Seneszenzzustand beobachten, was auf
einen Verlust der Regulation der L1-Elemente hinweist. Interessanterweise werden
L1-Elemente in Zellen, die die Seneszenz durchlaufen, hochreguliert. Wahrscheinlich
ist die Reaktivierung der L1-Elemente die Folge der Deaktivierung von Genen der
Wirtsabwehr (TRIM28 und APOBEC3B), die die Regulation von L1-Elementen
kontrollieren. Um eventuell irrefu¨hrende Befunde auf Transkriptionsebene zu ver-
meiden, habe ich zusa¨tzlich die Translationsmuster von L1-ORFs durch den Ein-
satz von Ribo-Seq u¨berpru¨ft. Bei der post-transkriptionalen Analyse habe ich in
den Zellen, die Seneszenz durchlaufen, ein signifikantes Muster von L1-kodierenden
Transkripten entdeckt. Diese Beobachtung la¨sst sich durch die Deaktivierung von
RNA-editierenden Enzymen erkla¨ren. Des Weiteren habe ich in silico die durch die
Enzyme ADAR und APOBEC3B hervorgerufenen RNA-editierenden Ereignisse in
sehr alten und mittelalten L1-Subfamilien untersucht. Ein deutlich unterschiedliches
APOBEC3B-abha¨ngiges RNA-Editierungsmuster konnte zwischen proliferierenden
und in Seneszenz befindlichen Zellen an den Loci der ju¨ngsten L1-Elemente, die
zum Springen fa¨hig sind, beobachtet werden. Wenn Einzelstrangbru¨cke in der DNA
einen gewissen Schwellenwert u¨bersteigen, generieren L1-Elemente Insertionen und
erzeugen wa¨hrend ihrer Integration in das Genom Doppelstrangbru¨che (DSBs). Ich
habe solche Insertionsereignisse durch den Nachweis chima¨rer Transkripte zwischen
L1-Elementen und genomischen Regionen gefunden. Interessanterweise war das
Motiv fu¨r Target Site- Duplikationen (TSDs) an der de novo-Verbindung von L1-
Elementen und genomischer Sequenz angereichert, was auf neue Insertionen in den
Seneszenz-Zellen hinweist. Unsere Ergebnisse lassen darauf schließen, dass exzessiver
onkogener Stress in immortalisierten Zellen mit dem Springen von L1-Elementen
einhergeht, wodurch Doppelstrangbru¨che verursacht und die Zellen befa¨higt werden,
in die zellula¨re Seneszenz u¨berzugehen.
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Appendix
In-Silico Dissection of L1 retrotransposons in Cel-
lular Senescence
Figure A.1: Chimeric transcript representation obtained from chimeric donor sites
for L1 elements capable of jumping. (A) Circos plot illustration of chromosome inter-
actions for proliferative cells exhibited 0 chimeric transcripts. (B) Analytical circos
plot representation of chromosome interactions for senescent cells exhibited 2 chimeric
transcripts.
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Figure A.2: Expression analysis in diverse families of L1 elements.(A) In L1PA5 sub-
family of elements it showed up-regulation of expression in proliferative as compare to
other conditions. (B) For L1PA7 subfamily of elements it also displayed up-regulation
in proliferative state as compare to other conditions.
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Figure A.3: RNA editing sites distribution in proliferative cells. The quarter of LIHs
and L1PA2 refers to youngest L1 family. The second quarter from L1PA3 to L1PA5
refers to middle-aged L1 family. The third quarter from L1PA6 to L1MA1 refers to
ancient L1 family.
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Figure A.4: De novo motif analysis for insertional events from Chimeric donor sites.
Target represents motif pattern of donor insertional event for senescent cells. While,
Query represents consensus sequence of TSDs.
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